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Abstract !
As a consequence of aging, the brain is subject to chronic 
neuroinflammatory conditions. The resident immune cells of the brain, 
microglia, act similarly to peripheral macrophages to protect the brain 
from insults, infection, and physical trauma. However, without proper 
regulation of their respective host defense mechanisms, these actions 
can become neurotoxic. In the healthy brain neurons have several 
signaling systems that directly interact with microglia in order to 
maintain a calming influence upon their actions, one of particular 
interest is the chemokine CX3CL1. This chemokine is found 
predominantly on neurons, while its cognate receptor CX3CR1 is found 
exclusively on microglia. There has been a recent surge in literature as 
to the exact role CX3CL1 signaling plays various physiological and 
neuropathological animal models, with still no well-defined role. In an 
attempt to address the current discordance regarding the role of 
CX3CL1 signaling we have used three different models. The first 
examines how genetic ablation of CX3CR1 impacts hippocampal 
dependent cognitive function. Secondly, we examined the impact of 
chronic LPS-induced neuroinflammation affects CX3CL1 signaling and 
ultimately cognitive function. Lastly, we used an acute mouse model of 
! v!
Parkinson’s disease induced by MPTP to examine the effects of specific 
subtypes of CX3CL1. Although three unique approaches were used to 
examine the anti-inflammatory properties of CX3CL1, parallels can be 
drawn from the separate studies as similar results were obtained. 
CX3CL1 signaling has significant anti-inflammatory actions within the 
brain and alterations that prevent this signaling to occur can result in 
impairments in cognitive function as well as exacerbation of 
neurodegenerative conditions. 
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Introduction 
Neuroinflammation has been concomitantly linked with aging 
and the progression of most neurodegenerative diseases including 
Alzheimer’s (AD), Parkinson’s (PD), multiple sclerosis, amyotrophic 
lateral sclerosis, stroke, and traumatic brain injury to name a few 
(Popovich 2000; McGeer, Klegeris et al. 2005; Boillée, Vande Velde et 
al. 2006; Wang, Tang et al. 2007; Hirsch and Hunot 2009; Weiner 
2009). Much work in the neuroscience community has been dedicated 
to studying the underlying mechanisms involved in the propagation of 
inflammatory events and conditions in the central nervous system 
(CNS). As a general summation, inflammation can be best described 
as the body’s natural reaction to insults, pathogens, tissue damage, 
and other deleterious stimuli. This response is typified by activation of 
immune regulatory systems, whereby a variety of cellular signaling 
events are orchestrated in an effort to provide host defense. While 
these synchronized responses are designed for protection, they can 
become dysfunctional in various disease conditions resulting in an 
imbalanced response both in the periphery and CNS.  
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Microglia 
Microglia are the resident immune cells in the CNS and thus the 
main inflammatory effectors in neurodegenerative diseases. Acting in 
parallel to the innate immune cells found in the periphery, microglia 
constitutively express a variety of cell-surface receptors, including toll 
like receptors (TLR), complement receptors, major histocompatibility 
complex (MHC) II, cytokine receptors, chemokine receptors, and 
others (Aloisi 2001). These receptors work in concert to trigger or 
amplfy an innate immune response within the CNS. Such a response 
can be observed when microglia are exposed to lipopolysaccharide 
(LPS), which is an endotoxin comprising the outer membrane of gram-
negative bacteria. Microglial response to LPS exposure has been well 
characterized by their upregulation in the production and secretion of 
proinflammatory cytokines such as interleukin one beta (IL-1β), tumor 
necrosis factor alpha (TNFα), and interleukin six (IL-6) (Lee, Liu et al. 
1993). Although neurons and astrocytes have been shown to produce 
inflammatory cytokines, their contribution has been shown to be 
minimal by comparison (Lee, Liu et al. 1993). Therefore, microglia are 
not only the sole innate immune effectors of the CNS, but must be 
considered as the primary supplier of inflammatory signaling molecules 
(Aloisi 2001). Microglia are dynamic in function in that they are 
constantly surveying their surrounding microenvironment for danger 
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signals such as neuronal damage. When neuronal damage occurs, 
microglia will effectively move to the site of damage, guided by various 
signaling gradients emanating from the damaged site/cell (Davalos, 
Grutzendler et al. 2005; Nimmerjahn, Kirchhoff et al. 2005). This 
dynamism comes through the extension and retraction of the cell’s 
processes, allowing microglia to be in a constant state of adaptive 
remodeling (Nimmerjahn, Kirchhoff et al. 2005). 
Roles of microglia in aging and disease 
While microglia in the brain are homogeneous in lineage, they 
are heterogeneous in nature. There has been much attention and 
effort to classify microglia based upon their neuroinflammatory 
phenotype by adopting knowledge of T-cell responses from the 
peripheral immune system(Mosser and Edwards 2008; Martinez, 
Helming et al. 2009). This research has led to the loose establishment 
of three microglia activation states (Mosser and Zhang 2008). The 
most well studied phenotype known as “classical activation” or 
Th1/M1. This activation state represents the initial phase of the CNS 
innate immune response. M1 polarization of microglia is characterized 
by the activation of these cells from LPS, interferon-γ!(IFN-γ), and 
various cytokines, akin to peripheral macrophages. Microglia of this 
phenotype are further characterized by antigen presentation and 
production of toxic levels of oxidative and nitrosative intermediates, as 
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well as increased pro-inflammatory cytokine production (Mantovani, 
Sica et al. 2004). Due to the intrinsic nature for producing potentially 
toxic levels of inflammatory mediators and perpetuating inflammation, 
M1 phenotype is the perhaps the best studied. While M1 activation is 
functionally the innate response to various insults in an effort to 
maintain host (brain) defense, there is another end to the spectrum 
regarding microglia activation to promote wound healing. These 
microglia/macrophages are representative of the Th2/M2 phenotype or 
“alternate activation” (Mosser and Edwards 2008). Characteristically, 
these cells produce very little pro-inflammatory cytokines. Instead,  
high levels of arginase activity are detected (Mosser and Edwards 
2008; Mosser and Zhang 2008; Martinez, Helming et al. 2009). One 
function of arginase is conversion of precursors to collagen, which 
contributes to production of the extracellular matrix (Raes, De 
Baetselier et al. 2002; Colton, Mott et al. 2006; Mosser and Zhang 
2008). The proposed polarity between activation states is somewhat 
ambiguous however, as there is a defined phenotype for M1, while the 
M2 label encompasses activation states that include everything not 
M1-like in nature (Mosser and Edwards 2008). This ambiguity yields 
distinct subclasses of M2 activation, presenting a third type known as 
“acquired deactivation” (Mosser and Zhang 2008). In this subclass of 
M2, the primary response of microglia sharply contrasts with M1 to up-
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regulate the production of growth factors, which ultimately act to 
resolve an inflammatory response. The inherent plasticity of microglia 
activation then yields a wide array of response in the brain ranging 
from inflammatory, to a build and repair mode, and finally to a calming 
or anti-inflammatory state.   
Innate immunity in cognitive function and disease 
The current knowledge regarding the activation of microglia and 
their respective roles in the brain implicates a dichotomous function 
wherein they serve as both neuroprotective and neurodegenerative. 
The responsibilities of microglia are quite vast when considered in the 
context of multiple diseases that affect the brain. For instance, it must 
be appreciated that such responses must be sufficiently distinct when 
considering stroke or traumatic brain injury compared to AD. In the 
case of the former neuronal death occurs very rapidly 
(minutes/hours), while in AD neuronal dysfunction and death occurs 
over years or decades!(Ransohoff and Perry 2009). Post stroke, a rapid 
response is needed to clear necrotic cells and tissue, however 
modulation of activated microglia is needed to avoid a chronic 
degenerative state. In contrast, in AD a combination of events are 
occurring over a long stretch of time as a result of misfolded protein 
(Perry, Cunningham et al. 2007). In this case, microglia too need a 
rapid response but rather possess a malleable role. It is therefore 
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difficult to have a broad-spectrum approach to the control of microglia 
toxicity when such a varied response is needed.  
The ability to remember is predicated on the brain’s capacity to 
form strong and efficient synaptic connections. These connections are 
in turn maintained by de novo expression from a variety of genes, 
which mediate synaptic plasticity (Rosi 2011). Importantly, 
dysfunction of hippocampal synaptic plasticity is associated with aging 
and many inflammation propagated neurodegenerative diseases such 
as AD, autism, and multiple sclerosis (McGeer and McGeer 1998; 
Akiyama, Barger et al. 2000; Mhatre, Floyd et al. 2004). While 
dysfunctional neurons cause the functional disorder of these diseases, 
alterations of their local niche may play an important factor in disease 
progression. It is therefore relevant to consider how microglia 
activation plays an integral role in neuronal function and synaptic 
plasticity.  
Although neuroinflammation is needed for host defense to 
protect against various insults (exogenous or endogenous), 
unregulated responses can be toxic. It is difficult to pinpoint a 
causative mechanism related to neuroinflammatory initiated cognitive 
impairments as a whole. However, in the context of the hippocampus, 
the role in which neuroinflammation may alter cognitive function could 
be its adverse impact on neurogenesis (Bachstetter, Pabon et al. 
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2008; Bachstetter, Morganti et al. 2009). Neurogenesis in the dentate 
gyrus (DG) of the hippocampal formation has been consistently linked 
hippocampal-dependent memory function (Imayoshi, Sakamoto et al. 
2008). Interestingly, there’s a direct correlation between the increase 
of infiltrating granule cells in the hippocampus with hippocampal 
dependent memory function (Shors, Miesegaes et al. 2001). The 
relevance of infiltrating granule cells into the hippocampus can be 
appreciated due to their ability to develop into mature neurons, 
exhibiting the synaptic responsiveness as their surrounding 
contemporaries (Song, Stevens et al. 2002). It is here where the 
inflammatory response of microglia has been implicated in creating 
unfavorable neurogenic microenvironments. Equally, aberrant 
activation of microglia has been shown to be toxic to not only 
new/infiltrating granule cells, but mature neurons as well (Monje and 
Palmer 2003). Furthermore, blocking neuroinflammation through 
various targets can restore or even increase neurogenesis (Monje, 
Toda et al. 2003; Gemma, Bachstetter et al. 2007; Das and Basu 
2008).  
 Neuroinflammation is a common denominator among many 
neurodegenerative diseases and, more often than not, is a culprit in 
the propagation of the disease. PD is a characteristic 
neurodegenerative disease where aberrant microglia activation and 
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subsequent neuronal toxicity are hallmarks (Block and Hong 2005; 
Ransohoff and Perry 2009)The substantia nigra, the affected area in 
PD, has been shown to contain roughly 4.5 times the population of 
microglia compared to other areas of the brain (Kim, Mohney et al. 
2000), potentially predisposing these neurons to greater microglial 
insults (Block and Hong 2005). The exact mechanism involving the 
deleterious effects of microglia on dopaminergic neurons is still 
evolving. Complicating the situation even more is that dopaminergic 
neurons have a greater susceptibility to oxidative stress from microglia 
due to reduced levels of glutathione (Loeffler, DeMaggio et al. 1994). 
Furthermore, a role for microglia-mediated neurotoxicity in PD is that 
mice, which are genetically altered to inhibit cytokine production or are 
deficient in receptors for cytokines, provide neuroprotection (Klevenyi, 
Andreassen et al. ; Sriram, Matheson et al.). As such, it is relevant to 
address methods that regulate of microglia-initiated inflammation and 
subsequent neurotoxicity,  
Fractalkine and CX3CR1 
Recent evidence indicates that neurons are not only passive 
targets of microglia but rather can control microglia activity.  An 
important area of investigation is to examine neuronal-glia 
interactions, as this is one way that neurons can signal inflammatory 
cells that a response is needed.  Under resting conditions there are 
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several neuronal mediated signals that have an anti-inflammatory 
action at the level of microglia.  One of high interest in the literature is 
the chemokine CX3CL1 (FKN). FKN is expressed constitutively by 
healthy neurons and it has been identified as a novel neuroimmune 
regulatory protein, whose function is to send alert signals to microglia, 
and inhibit microglia activity under inflammatory conditions (Harrison, 
Jiang et al. 1998; Ransohoff, Liu et al. 2007). Compared to most 
chemokines, FKN is unique in size and structure. FKN in its full-length 
form is approximately 100 kDa in weight, compared to 8-14kDa of 
most common chemokines, and comprises an intracellular 
transmembrane domain as well as a glycosolated mucin-like stalk 
(Bazan, Bacon et al. 1997; Imai, Hieshima et al. 1997; Rossi, 
Hardiman et al. 1998)Furthermore, FKN is unique among the large 
super-family of chemokines in that it is the only member to have a 
CX3C-arrangement of its conserved cysteine residues (Maciejewski-
Lenoir, Chen et al. 1999). Additionally, FKN ligates and activates only 
a single receptor, CX3CR1. Ligation and signaling from FKN can occur 
via two mechanisms; the chemokine domain can be shed, to form a 
soluble form, from the membrane via a disintegrin and 
metalloproteinase 10 (ADAM10) and TNFα converting enzyme 
(TACE/ADAM17), or chemokine domain may remain tethered to the 
membrane in a signaling capable full-length form (Garton, Gough et al. 
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2001; Hundhausen, Misztela et al. 2003; Hundhausen, Schulte et al. 
2007). Expression of FKN is ubiquitous however; only certain cell types 
in the CNS and periphery have been shown to produce it. Within the 
CNS, FKN is constitutively produced by neurons, with a few instances 
where it may be induced or upregulated in astrocytes depending upon 
insult or disease (Harrison, Jiang et al. 1998; Yoshida, Imaizumi et al. 
2001; Guillemin, Croitoru-Lamoury et al. 2003). Interestingly, FKN and 
stromal cell-derived factor-1 (SDF-1/CXCL12) are two of the only 
known constitutively expressed chemokines found in neurons (Crump, 
Gong et al. 1997; Mizoue, Bazan et al. 1999). Furthermore, recent 
data have implicated a unique relationship between FKN and SDF-1, 
wherein SDF-1 has been implicated in stimulating the actions of 
ADAM10/17 upon FKN to produce its secreted form (Cook, Hippensteel 
et al. 2010). Outside of the CNS, FKN expression is found on several 
cells types; endothelial, epithelial, and smooth muscle cells (Bazan, 
Bacon et al. 1997; Ludwig, Berkhout et al. 2002; Teupser, Pavlides et 
al. 2004). In terms of the CNS, several studies have suggested a 
continuous dialog between neurons and microglia under basal 
conditions via FKN and its cognate receptor CX3CR1 (Ransohoff, Liu et 
al. 2007). This interaction between FKN and CX3CR1 contributes to 
maintain microglia in a resting phase. Both in vivo and in vitro FKN-
CX3CR1 dialog has been shown to hamper production of multiple pro-
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inflammatory mediators such as iNOS, IL-1β, TNFα, and IL-6, as well 
as confer neuroprotection against various insults and disease models 
(Harrison, Jiang et al. 1998; Boehme, Lio et al. 2000; Meucci, Fatatis 
et al. 2000; Zujovic, Benavides et al. 2000; Zujovic, Schussler et al. 
2001; Zujovic and Taupin 2003; Cardona, Pioro et al. 2006; 
Bachstetter, Morganti et al. 2009; Lyons, Lynch et al. 2009; Lyons, 
McQuillan et al. 2009; Pabon, Bachstetter et al. 2011). Therefore, 
disruption of this dialog could trigger changes in the functional 
phenotype of microglia.   
FKN cognate receptor is CX3CR1, which is expressed solely by 
microglia in the CNS. In the periphery, CX3CR1 can be found on a 
variety on circulating immune cells including monocytes, dendritic 
cells, certain T-cells, and natural killer cells (Harrison, Jiang et al. 
1998). It is therefore difficult to generalize the exact nature of FKN-
CX3CR1 given the variety of cells capable of ligation with FKN. 
Furthermore, this signaling pair’s interactions vary according to their 
resident tissues and as of recently, various disease models. A dual role 
for FKN and CX3CR1 are observed in the literature raising the question 
as to the risk/benefit of FKN-CX3CR1 signaling as a therapeutic tool. 
As mentioned above, within the brain the majority of literature seems 
to indicate a calming effect produced by FKN ligation to CX3CR1. 
Conversely, in different models of AD genetically blocking FKN-CX3CR1 
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signaling can be either neuroprotective!(Lee, Varvel et al. 2010; Cho, 
Sun et al. 2011) or neurodegenerative (Fuhrmann, Bittner et al. 
2010). Additionally, in humans there are 2 polymorphisms for the 
CX3CR1, one of which caused reduced adhesion, signaling and 
chemotaxis.  The variant with reduced adhesion is protective for 
atherosclerosis (McDermott, Fong et al. 2003) yet increases the risk of 
macular degeneration (Tuo, Smith et al. 2004). Comparatively, 
CX3CR1 null mice show markedly increased cytokine storm in response 
to lipopolysacharide (LPS) resulting in a subsequent increase in cell 
death in the hippocampus. CX3CR1 null mice also show increased 
susceptibility to neurotoxins such as MPTP (Cardona, Pioro et al. 
2006), presumably by an increased classical activation state of 
microglia.  
An aspect of FKN-CX3CR1 signaling that may play an important 
role in the differential effects of FKN is its ability to ligate CX3CR1 as 
both a soluble and membrane-bound chemokine. FKN is cleaved at a 
dibasic arginine sequence adjacent to the cell membrane to produce a 
soluble form of its signaling domain (Ré and Przedborski 2006). The 
exact roles of these subtypes of FKN are not completely established in 
the periphery or in the CNS.  It has been shown that the membrane 
bound form plays a role in endothelial cell death (Yoneda, Imai et al. 
2003) whereas exogenous soluble FKN has been shown to be both 
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neuroprotective (Pabon, Bachstetter et al. 2011) and 
neurodegenerative (Shan, Hong-Min et al. 2011). Recently, Lyons et 
al. (2009) (Lyons, Lynch et al. 2009) were able to show a significant 
reduction in microglia activation in vitro using exogenous soluble FKN. 
Furthermore, they concluded that the membrane-bound form of FKN 
possesses the same abilities, however due to their experimental 
parameters it is unclear whether signaling was achieved solely from 
the membrane-bound subtype. Importantly, the authors neglected to 
prevent the potential cleavage by ADAM10/17, which would result in 
the production of the soluble subtype. Therefore, the physiological 
significance of both subtypes of FKN still remains ambiguous.  
Conclusion 
The overall hypothesis that underlies the focus of this 
dissertation is that disruption in neuron to microglia interaction leads 
to inflammation. Furthermore, this disconnect establishes an 
environment that is at least permissive and perhaps a critical 
contributor towards the inflammation-mediated decline in synaptic 
plasticity, and for the progression/exacerbation of neurodegenerative 
diseases, such as in PD. The following chapters of this dissertation 
address three distinct models in which neuron to microglia 
communication has been altered and how the CX3CL1 signaling plays a 
vital role to maintain microglia in a resting state. 
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Abstract 
The protective/neurotoxic role of fractalkine (CX3CL1) and its 
receptor CX3C chemokine receptor 1 (CX3CR1) signaling in 
neurodegenerative disease is an intricate and highly debated research 
topic and it is becoming even more complicated as new studies reveal 
discordant results.   It appears that the CX3CL1/CX3CR1 axis plays a 
direct role in neurodegeneration and/or neuroprotection depending 
upon the CNS insult.   However, all the above studies focused on the 
role of CX3CL1/CX3CR1 signaling in pathological conditions, ignoring 
the relevance of CX3CL1/CX3CR1 signaling under physiological 
conditions.   No approach to date has been taken to decipher the 
significance of defects in CX3CL1/CX3CR1 signaling in physiological 
condition.   In the present study we used CX3CR1-/-, CX3CR1+/- and 
wild-type mice to investigate the physiological role of CX3CR1 receptor 
in cognition and synaptic plasticity.   Our results demonstrated for the 
first time that mice lacking CX3CR1 receptor show contextual fear 
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conditioning and Morris water maze deficits.   CX3CR1 deficiency also 
affects motor learning.   Importantly, mice lacking the receptor have a 
significant impairment in long term potentiation (LTP).   Infusion with 
IL-1b receptor antagonist significantly reversed the deficit in cognitive 
function and impairment in LTP.  Our results reveal that under 
physiological conditions, disruption in CX3CL1 signaling will lead to 
impairment in cognitive function and synaptic plasticity via increased 
action of IL-1b. 
 
INTRODUCTION 
Microglia are the resident immune cells in the central nervous 
system (CNS) that act as macrophages (Harrison, Jiang et al. 1998; 
Aloisi 2001).   Microglia can rapidly respond to the detection of 
homeostatic disturbances by inducing an immune response, which 
consists of a transient, up-regulation of inflammatory molecules and 
neurotrophic factors (Miwa, Furukawa et al. 1997; Batchelor, 
Liberatore et al. 1999; O'Donnell, Vereker et al. 2000; Nakajima and 
Kohsaka 2004). Through this immune response, microglia protect 
proper brain function and remove cells damaged from an acute injury. 
When chronic inflammation occurs, prolonged activation of microglia 
trigger the release of several neurotoxic products and proinflammatory 
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cytokines including IL-1b, IL-6, and Tumor necrosis factor (TNFa) 
(Colton and Gilbert 1987). 
Microglia are restrained by numerous micro-environmental 
influences, many of which are produced by neurons (Cardona, Pioro et 
al. 2006; Hanisch and Kettenmann 2007; Lyons, Downer et al. 2007). 
Fractalkine (CX3CL1) is a chemokine that is constitutively expressed 
by healthy neurons and identified as a novel neuroimmune regulatory 
protein.  CX3CL1 ligates to microglia, which inhibits microglial activity 
under inflammatory conditions (Harrison, Jiang et al. 1998; Ransohoff, 
Liu et al. 2007). In contrast to other chemokines, CX3CL1 binds to 
only one receptor, CX3CR1 (Harrison, Jiang et al. 1998).   In the brain 
CX3CR1 is exclusively expressed by microglia (Harrison, Jiang et al. 
1998). CX3CL1 can bind to CX3CR1 either as a membrane bound 
protein or a soluble ligand following constitutive cleavage by ADAM10 
and ADAM17 metalloproteases (Bazan, Bacon et al. 1997). 
Interactions between CX3CL1 and CX3CR1 contribute to microglial 
ability to maintain a resting phenotype.   However, when neurons are 
injured, CX3CL1 levels decrease, which results in microglia recruitment 
and activation.    
Through interactions with microglia, CX3CL1 serves as an 
endogenous neuronal modulator and controls the over-production of 
iNOS, IL-1b, TNFα and IL-6.   Interestingly, CX3CL1/CX3CR1 signaling 
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has been linked to human neurodegeneration, highlighted by the 
identification of the V249I and T280M polymorphisms in CX3CR1.   
These polymorphisms are associated with the neuroinflammatory 
disorder, human age-related macular degeneration (Tuo, Smith et al. 
2004; Chan, Tuo et al. 2005).   Furthermore, mice that are deficient in 
CX3CR1 have increased microglial cell expression of IL-1β in response 
to lipopolysacharide (LPS) stimulation.   This increased IL-1β 
expression is associated with increased neuronal cell death in the 
hippocampus (Cardona, Pioro et al. 2006; Ransohoff, Liu et al. 2007) 
and CX3CR1-deficent mice have increased susceptibility to neurotoxins 
such as MPTP (Cardona, Pioro et al. 2006). However, all of the studies 
mentioned have focused on the role of CX3CL1/CX3CR1 signaling in 
pathological conditions, ignoring the relevance of CX3CL1/CX3CR1 
signaling under physiological conditions.   Our lab has previously 
established the impact of functional disruption of CX3CR1 in a non-
pathological condition.   We have demonstrated that CX3CR1-/- mice 
have decreased hippocampal neurogenesis(Bachstetter, Morganti et al. 
2009).   Furthermore, antagonism of CX3CR1 in young rats leads to 
increased hippocampal protein levels of IL-1b and decreased 
neurogenesis.   We hypothesize that disruption of CX3CL1/CX3CR1 
signaling will result in alterations of the physiological activities of the 
brain.   Here, we demonstrate under physiological conditions, 
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disruption of CX3CL1/CX3CR1 signaling leads to impairments in motor 
learning, cognitive function and synaptic plasticity through increased 
inflammation in the CNS. 
MATERIALS AND METHODS 
Animals.   All experiments were conducted in accordance with 
the National Institute of Health Guide and Use of Laboratory Animals, 
and were approved by the Institutional Animal Care and Use 
Committee of the University of South Florida, College of Medicine or 
the University of Florida, as appropriate.   CX3CR1-/- mice were 
backcrossed to the C57BL/6J background for greater than 10 
generations and were obtained from Jackson Laboratories (Bar Harbor, 
Maine).  Colonies of the CX3CR1+/- and CX3CR1-/- mice were 
maintained at the University of South Florida and genotyping 
performed as previously described (Bachstetter, Morganti et al. 2009).   
Three month-old male CX3CR1+/- and CX3CR1-/- littermates and 
C57BL/6J (wild-type) were used in the experiments.   Mice were pair-
housed in environmentally controlled conditions (12:12 h light:dark 
cycle at 21 ± 1°C) and provided food and water ad libitum.   Animals 
that developed skin lesions were excluded from the Morris water maze 
test to avoid the development of infection. 
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BrdU administration.   Three month-old male (n = 
5/genotype) CX3CR1+/-, CX3CR1-/- littermates and C57BL/6 (wild-type; 
WT) received two intraperitoneal (i.p.) injections within 12 hours 
interval of bromodeoxyuridine (BrdU) (5-bromo-2-deoxyuridine; 
Sigma, St.  Louis, MO) at dose of 50 mg/kg.   Animals were 
euthanatized 24 hours following the last injection. 
 
Surgical procedure.   Three month-old male CX3CR1-/- and 
C57BL/6 (wild-type; WT) mice were implanted with a brain infusion 
cannula connected with an osmotic mini-pump.   Before implantation, 
the pumps were incubated in sterile saline for at least 48 h at 37 °C to 
prime the pumps.   For implantation, mice were anaesthetized with 
isofluorane and placed in a stereotaxic frame.   A guide cannula was 
implanted in the left ventricle AP, 1.0; ML, -0.5; DV, 2.5 mm) and 
connected to the osmotic minipump (Alzet Model, 1004: pumping rate, 
0.11 ml ⁄ h; total volume, 100 ml), which was inserted 
subcutaneously.   Pumps were weighed before implantation and at the 
end of the experiment to ensure complete delivery of their content.   r-
metHu IL-1ra, 100 mg/ml/day (kind gift from Amgen,Thousand Oaks 
CA), was infused through the cannula which was connected to the 
filled mini-pump.   The infusion started on the day of the surgery and 
continued for 4 weeks.   Control animals received the same volume of 
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heat-inactivated IL-1ra (heat-inactivated for 45 minutes in a water 
bath at 90oC) or artificial cerebrospinal fluid (ACSF).   Behavioral 
analysis started 15 days following the beginning of the infusion.   Mice 
that during the course of behavioral testing showed signs of distress or 
infections during to surgical procedure were not included in the 
following behavioral studies.    
 
Tissue collection and processing.   For immunohistochemistry 
studies, animals were anaesthetized with pentobarbital (50 mg/kg, 
i.p.).   The mice were transcardially perfused with phosphate-buffered 
saline (PBS), followed by 4% paraformaldehyde in PBS.   The brains 
were postfixed in 4% paraformaldehyde for 12 h, after which they 
were transferred into 30% sucrose in PBS for at least 16 h at 4°C.   
Exhaustive sagittal sections of the left hemisphere were made at 40µm 
using a Microm cryostat (Richard-Allan Scientific, Kalamazoo Michigan) 
and stored in cryoprotectant at 4°C.   Animals used for biochemical 
studies were euthanatized by rapid decapitation.   Brain tissues were 
separately dissected and rapidly frozen in liquid nitrogen before 
storage at -80ºC.   Both hippocampi were homogenized using an 
electric tissue homogenizer in 1:10 weight to volume ratio of ice-cold 
RIPA buffer (Millipore; Billerica MA) containing protease inhibitors and 
EDTA (Pierce; Rockford IL).   Following homogenization, sample 
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lysates were centrifuged at 10,000 x g at 4ºC for 15 minutes, the 
cleared supernatant was collected.   
ELISA.   Total protein was measured using BCA assay (Pierce).   
IL-1β and TNFα concentrations were measured using a commercially 
available enzyme-linked immunosorbent assay (ELISA) kits 
(eBioscience; San Diego CA) following manufacturer’s protocol.    
Western blot analysis.   50 µg of total protein per lane was 
loaded onto a 10% SDS-polyacrylamide gel (BioRad; Hercules CA) for 
electrophoresis.   Proteins were transferred onto a nitrocellulose 
membrane for immunodetection.   The membrane was blocked for 1-
hour in 5% non-fat dry milk (NFDM) in PBS-tween (PBS-T, 0.1%).   
Antibodies for rabbit phospho-p38 (Cell Signaling; Boston MA, 1:1000) 
and mouse beta-actin (Sigma; 1:3000) were incubated overnight at 
4oC in 1% NFDM in PBS-T.   Following washes, anti-rabbit and anti-
mouse secondary antibodies (LiCor; Lincoln NE) were incubated for 1-
hour at room temperature in 1% NFDM in PBS-T.   Membranes were 
scanned using LiCor Odyssey Imager and raw intensity for each band 
was measured using LiCor Odyssey image analysis software.   
Immunohistochemistry. Except where specifically indicated, 
standard staining procedures were conducted on free-floating sections 
using every sixth section for the entire hippocampus beginning with a 
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random start and including sections before and after the hippocampus 
to ensure that the entire structure was sampled.   Sections were 
blocked in 10% normal serum from the species that secondary 
antibody was raised in, with the addition of 0.1% Triton X-100.   
Sections were incubated, with primary antibody (Abcam anti Iba1 
1:500) diluted in 3% normal serum with 0.1% Triton X-100, overnight 
at 4°C.   For immunohistochemistry biotinylated secondary antibodies 
(horse anti-goat 1:2000) were diluted in 3% normal serum with 0.1% 
Triton X-100 and were incubated for 2 hours at room temperature.   
Enzyme detection was done using avidin-biotin substrate (ABC kit, 
Vector Laboratories, Burlingame, CA) followed by color development in 
diaminobenzidine solution (Sigma, St. Louis, MO).   For immuno-
detection of BrdU labeling, protocol was followed as previously 
described (Bachstetter et al., 2009;Gemma et al., 2007).   Briefly, 
sections were pretreated with 50% formamide/2× SSC (0.3 M NaCl, 
0.03 M sodium citrate) at 65°C for 2 hours, rinsed in 2 × SSC.   BrdU 
was detected using a mouse anti-BrdU (1:100; Roche; Indianapolis IN, 
clone B44).   Doublecortin (DCX) is a marker of migrating neurons that 
is expressed for approximately three weeks after the cell is born and 
has been shown to be a reliable indicator of neurogenesis (Rao and 
Shetty 2004; Couillard-Despres, Winner et al. 2005).   For DCX 
immuno-detection, incubation in primary antibody was done for 36 
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hours at 4°C using a polyclonal goat antibody C-terminus of human 
DCX (1:200; Santa Cruz biotechnology, Santa Cruz, CA, USA).   
Quantification and imaging. To determine cell numbers, the 
optical fractionator method of unbiased stereological cell counting 
techniques (West, Slomianka et al. 1991) was used with a Nikon 
Eclipse 600 microscope and quantified using Stereo Investigator 
software (MicroBrightField, Colchester, VT).   The virtual grid (175 x 
175) and counting frame (100 x 100) were optimized to count at least 
200 cells per animal with error coefficients less than 0.07.   Outlines of 
the anatomical structures were done using a 10x/0.45 objective and 
cell quantification was conducted using a 60x/1.40 objective.   
Iba1 quantification. Slides with Iba1 stained sections were 
scanned using a Zeiss Mirax slide scanner.   Following scanning, digital 
images were analyzed for Iba1 positive staining using Zeiss 
Neuroquant IAE analysis software.   Briefly, an investigator blind to the 
study randomly placed a measurement grid within the DG of each HPC 
section.   Each measurement grid had the same dimensions and 
therefore same measurement area.   Iba1 positive cells were defined 
in the analysis software based upon threshold to include both the cell 
body and processes, while eliminating background values.   Data were 
obtained solely from the randomly placed measurement grid on an 
average of five sites per animal within the DG.   Raw data were 
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normalized to account for variations in the number of sampling sites.   
Results are given as the average ratio of Iba1 positive area relative to 
total measurement area.   
Behavioral analysis.    
Rotarod. Aged-matched 3-month-old wild-type, CX3CR1-/-, and 
CX3CR1+/- mice were first tested for overall balance, motor 
coordination and motor learning.   This test was performed on an 
accelerating rotarod apparatus (Ugo Basile, Italy) with a 3 cm 
diameter rod starting at an initial rotation of 4 RPM accelerating to 40 
RPM over 5 minutes.   Mice were tested for the time spent on the rod 
during each of four trials with a 30 min inter-trial interval.   Each trial 
was completed when the mouse fell off the rod (distance of 12 cm) 
onto a spring-cushioned lever.    
Open Field. The open field was used as a standard test of 
general activity.   Animals were monitored for 15 minutes in a 40 cm 
square open field with a video tracking software (ANY-Maze, Stoelting, 
Illinois), under moderate lighting.   General activity levels were 
evaluated by determining the total amount of distance traveled.   
Anxiety levels were assessed by the pattern of exploration of in the 
open-field (center versus periphery).    
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Elevated Plus Maze. Anxiety was also assessed through the 
elevated plus maze (EPM).   The EPM consisted of two well-lit open 
arms (35 cm) facing each other and two enclosed arms (30.5 cm) also 
facing each other.   Each arm is attached to a common center platform 
(4.5 cm square) and elevated 40 cm off the floor.   The mouse was 
placed in the center platform and allowed to explore for 5 min.   Video 
tracking software measured movement in each section (ANY-Maze, 
Stoelting, Illinois). 
Fear Conditioning. Fear conditioning was used to assess 
memory formation that is especially suited to test for proper 
hippocampus function.  Animals were placed in the fear conditioning 
apparatus (Panlab, Spain) for 2 minutes, then a 30 second acoustic 
conditioned stimulus (CS; 80 dB tone) was delivered and a 0.5 mA 
shock (unconditioned stimulus-US) was applied to the floor grid during 
the last 2 seconds of the CS.  Training consisted of two CS-US pairings 
with a 1.5 minute interval between each.  The mice were placed in the 
chamber and monitored for freezing to the context 24 hours after 
training (no shocks or conditioned stimulus given).  Immediately after 
the contextual test, mice were placed into a novel context and 
exposed to the CS for 3 minutes (cued fear conditioning).  Learning 
was assessed by measuring freezing behavior (i.e. motionless position) 
for 2 consecutive seconds.  Shock threshold was assessed by placing 
!!
27!
an animal in the same conditioning chamber as used for associative 
fear conditioning.  Foot shock intensity started at 0.075 mA and was 
increased by 0.05 mA every 30 s.  The shock intensity to induce 
flinching, jumping, and vocalization were determined and the shock 
intensity was recorded.  The experiment was terminated at the shock 
intensity sufficient to induce vocalization. 
 
 
Morris Water Maze. The Morris hidden platform water maze 
(MWM) consisted of a circular pool (1.38 m diameter) filled with non-
toxic opaque water at room temperature with an escape platform (10 
cm diameter) hidden beneath the water (3 cm).  Each mouse was 
placed in the pool in a pseudorandom order and given 60 seconds to 
locate the escape platform.  When the mouse found the platform or if 
the mouse failed to find the platform within 60 seconds, it was placed 
on the platform where it remained for 30 seconds.  Each mouse was 
given four trials per day with an inter-trial interval of 1 hour.  The time 
to find the platform (escape latency), the total distance traveled, and 
the swim speed of the animals were recorded by video tracking 
software (ANY-Maze, Stoelting, Illinois).  The mice were then towel-
dried and placed in a cage with a heating pad underneath until dry and 
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returned to their home cage.  On day 7, all mice were subjected to one 
probe trial in which the platform was removed and each animal had 60 
seconds to search the pool for the platform.  Since wild-type mice did 
not show improvement in learning ability to find the platform on day 7, 
a second probe trial was performed on day 11, following 3 additional 
continuous days of training.    
Extracellular Recordings. Mice were euthanatized by rapid 
decapitation and hippocampi were dissected out for 
electrophysiological experimental paradigms as previously described 
(Weeber, Beffert et al. 2002; Beffert, Weeber et al. 2005; Peters, Hill 
et al. 2006). Field excitatory post-synaptic potentials (fEPSPs) were 
obtained from area CA1 stratum radiatum with the use of a glass 
microelectrode filled with ACSF (2–4 mΩ).  fEPSPs were evoked 
through stimulation of the Schaffer collaterals using a 0.1 ms biphasic 
pulse delivered every 20 s.  After a consistent response to a voltage 
stimulus was established, threshold voltage for evoking fEPSPs was 
determined and the voltage was increased incrementally every 0.5 mV 
until the maximum amplitude of the fEPSP was reached (I/O curve).  
All other stimulation paradigms were induced at the same voltage, 
defined as 50% of the stimulus voltage used to produce the maximum 
fEPSP amplitude, for each individual slice.  Paired-pulse facilitation 
(PPF) was induced with two paired-pulses given with an initial delay of 
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20 ms and the time to the second pulse incrementally increased 20 ms 
until a final delay of 300 ms was reached. 
LTP recordings. Slices that received IL-1ra (100 µg/ml kind gift 
from Amgen, Thousand Oaks CA) were bathed in ACSF containing IL-
1ra for at least 15 min prior to the start of recordings.  A fEPSP LTP 
baseline response was recorded every 20 sec for 20 min.  The tetanus 
used to evoke LTP was high-frequency stimulation (HFS), which 
consisted of 2 trains of 1 sec, 100 Hz pulses, with an inter-train 
interval of 20 s.  Following HFS, fEPSPs were recorded for 60 min.  The 
slopes of fEPSPs were averaged into 1 min bins and graphed.   
Potentiation was measured as the increase of the mean fEPSP 
descending slope following TBS normalized to the mean fEPSP 
descending slope of baseline recordings. 
PTP recordings. All hippocampal slices were bathed in ACSF 
containing 50 uM APV for at least 15 min prior to recordings.  Slices 
that received IL-1a were bathed in ACSF containing IL-1ra for at least 
15 min prior to the start of recordings.  A fEPSP PTP baseline response 
were recorded every 3 sec for 1 min.  The tetanus used to induce PTP 
was high-frequency stimulation (HFS), which consisted of a 1 sec, 100 
Hz pulses.  Following HFS, fEPSPs were recorded every 3 sec for 5 
min.  The slopes of fEPSPs were averaged into 12 sec bins and 
graphed.   Potentiation was measured as the increase of the mean 
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fEPSP descending slope following PTP normalized to the mean fEPSP 
descending slope of baseline recordings.   
DAPI Staining. Mice were sacrificed and hippocampi were 
dissected out for DAPI staining in the exact same manner as 
electrophysiological experimental paradigms. Hippocampal slices were 
placed in a submerged holding chamber containing oxygenated ACSF 
for no less than two hours before being transferred to 4% PFA for 
fixation for approximately 16 hours. Following fixation, 40 µm sections 
were made through entire dissected region and mounted on superfrost 
slides. Visualization of cell nuclei was achieved using DAPI VectaShield 
hardest mounting media (Vector Labs, Burlingame, CA). Fluorescent 
images were taken using Olympus FluoView FV1000 confocal 
microscope. Hippocampal DAPI positive cells were quantified from 16-
bit grayscale images using ImageJ software for each of the three 
genotypes (n=5 per group).  
Statistical Analysis. Statistical analysis comparing the 3 
genotypes was done using a one-way analysis of variance (ANOVA) or 
two-way ANOVA with the Tukey-Kramer or Bonferroni  post-hoc test,.  
Repeated Measure ANOVA was used to analyze Rotarod data, followed 
Bonferroni post-hoc.   Statistical analysis was done in the GraphPad 
Prism software. 
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RESULTS 
Decreased hippocampal neurogenesis in CX3CR1-deficient 
mice in a gene-dose dependent manner. Previously, we 
demonstrated that CX3CR1-/- young mice have a significant decrease 
in hippocampal neurogenesis when compared to heterozygous 
littermates.  To determine whether both alleles are required for normal 
receptor function, we counted the number of doublecortin (DCX) 
positive cells in the subgranular zone (SGZ) of the dentate gyrus in 
CX3CR1-/-, CX3CR1+/-, and wild-type mice.  Using the optical 
fractionator method of design-based stereology, we observed a 
significant decrease in the number of DCX+ cells in the SGZ of the 
dentate gyrus in CX3CR1-/-  mice compared to CX3CR1+/- and wild-type 
mice (Figure 1a; one-way ANOVA, p< 0.0001).  Interestingly, loss of 
one allele is sufficient to impair receptor function (Tukey’s post-hoc; 
wt vs +/- , p< 0.001; wt vs -/-,  p< 0.001; +/- vs -/-, p< 0.05).  To 
determine if this decrease is due to reduced cell proliferation, mice 
were injected twice (8 hours interval) with BrdU (50mg/kg).   Mice 
were euthanized the following day.  Quantification of the number of 
BrdU+ cells revealed a significant decrease in the number of BrdU+ 
cells in the CX3CR1-/- mice compared to the CX3CR1+/- and wild-type 
mice, indicating reduced cell proliferation (Figure 1b; Tukey’s post-
hoc; wt vs +/-, p< 0.05; wt vs -/-, p< 0.001; +/- vs -/-, p< 0.05).    
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Motor learning but not motor coordination is impaired in 
CX3CR1 deficient mice. Coordination and motor skill acquisition 
were tested using an accelerating rotorod.  The amount of time an 
animal stays on the rotorod is an indicator of its general level of 
balance and coordination.  In general, mice improve their performance 
over time with training, which is an indicator of motor learning.   In 
the first study, aged-matched littermate wild-type (n = 10), CX3CR1-/- 
(n = 12) and CX3CR1+/- (n = 12) mice were tested for the time spent 
on the rod during each of four trials per day, for two consecutive days.  
No differences were observed between genotypes during the first day 
of training (Fig 2a).  On the second day of training (trials 5-8), wild-
type mice remained on the rod for longer periods of time.   However, 
neither the CX3CR1-/- or the CX3CR1+/- mice significantly improvement 
motor coordination on the second day of training (Figure 2a; repeated 
measures ANOVA, p<0.0001.).  Wild-type mice performed significantly 
better on trial 8 compared to trial 1 than did CX3CR1-/- and CX3CR1+/- 
mice (Figure 2b), suggesting motor learning deficits in CX3CR1-/- and 
CX3CR1+/- mice.  There were no significant differences on the first trial 
of testing between all experimental groups, which suggests that there 
is no difference in baseline motor skills.   Taken together, these data 
suggest that CX3CR1-/- and CX3CR1+/- mice have deficits in motor 
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learning, indicating that cerebellar or striatal-dependent learning may 
be compromised in these mice.    
Absence of CX3CR1 receptor does not affect spontaneous 
locomotor activity or cause excessive anxiety. To examine 
spontaneous locomotor activity in response to a novel environment, 
CX3CR1-/-, CX3CR1+/- and wild-type mice were tested in the open field 
behavioral task.  The open field task monitors activity in a brightly lit, 
novel environment and is a necessary control for interpretation of 
associative fear conditioning.  Spontaneous locomotor activity was 
assessed as the total amount of distance traveled in the chamber.  
Also, anxiety levels can be measured in the open field task through 
assessment of the distances traveled in the center versus perimeter of 
the chamber.  This task exploits the natural tendency of mice to avoid 
open areas.  There were no significant differences in total distance 
traveled (Figure 2c).  In addition, no differences were observed 
between distance traveled in the center zone compared to the 
perimeter zone and the time spent in each zone (data not shown).  
Anxiety levels were also measured using elevated-plus maze task.  
Mice generally prefer to be in the closed arms of the maze, but their 
natural curiosity compels them to explore their environment.  Their 
level of anxiety was determined by the amount of time spent exploring 
the open arms of the maze versus the time spent in the closed arms.  
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CX3CR1-/- and CX3CR1+/- spent similar amounts of time in the open 
arms and in the center zone compared to wild-type mice (data not 
shown).  Taken together, the absence of the CX3CR1 receptor does 
not impair spontaneous locomotor activity nor cause excessive 
anxiety-like behavior.        
Impairment of cognitive function in CX3CR1 deficient 
mice. Hippocampal-dependent associative learning and memory was 
assessed in CX3CR1-/-, CX3CR1+/- and wild-type mice using contextual 
fear conditioning (CFC) and cued fear conditioning.  Animals were 
trained with a standard two-shock protocol as previously described 
(Weeber, Beffert et al. 2002). Freezing to the context (hippocampal-
dependent) or to the conditioned stimulus in a novel context 
(hippocampal- and amygdala-dependent) was used as an index of 
memory formation.  During training, CX3CR1-/- and CX3CR1+/- 
displayed similar freezing behavior compared to wild-type mice (Figure 
3a).  When placed in the context twenty-four hours following training, 
CX3CR1-/- and CX3CR1+/- show a decrease in freezing to the context 
compared to wild-type mice (Figure 3b; One-way ANOVA, Bonferroni 
post-hoc = p< 0.001).  Interestingly, CX3CR1+/- mice were 
significantly different from the CX3CR1-/- mice, further suggesting that 
the loss of one allele is sufficient to affect receptor function.  When 
placed in the novel environment and presented with the conditioned 
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stimulus, there were no significant differences between CX3CR1-/-, 
CX3CR1+/- and wild-type mice, suggesting that the behavioral deficits 
may be limited to hippocampal-dependent behaviors (Figure 3c). To 
further assess hippocampal-dependent learning and memory, the 
same group of mice was tested in the hidden platform water maze 
(HPWM) task.  There were no significant differences in escape latencies 
between experimental groups during training (Figure 3d).  However, 
both CX3CR1 -/- and CX3CR1+/- mice had a significant decrease in the 
number of target platform crossings during the probe trial compared to 
wild-type mice (Figure 3e; One-way ANOVA followed by Bonferroni 
post-hoc: p<0.05).  No differences were observed between 
experimental groups on the visible platform test (data not shown).  
These data further support the role of the CX3CR1 receptor to 
modulate hippocampal-dependent learning and memory.    
CX3CR1 deficient mice have impaired long-term 
potentiation (LTP). LTP is the most widely studied cellular model of 
memory.  The observation that CX3CR1 -/- and CX3CR1 +/- mice have 
deficiencies in both associative and spatial memory led us to 
determine whether the hippocampal-dependent memory deficits 
observed in these mice correlate with a reduction in synaptic plasticity.   
Both CX3CR1 -/- and CX3CR1 +/- mice showed significantly reduced 
hippocampal-dependent LTP compared to wild-type controls (Figure 
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4a-c).  Interestingly, examination of basal synaptic transmission 
revealed no differences between experimental groups (data not 
shown), suggesting that the decrease in LTP may be due to post-high 
frequency stimulation-dependent cellular mechanisms and may not 
represent differences in overall synaptic transmission.  Additionally, 
short-term plasticity evaluated by paired-pulse facilitation (PPF) is 
found to be normal in these mice, further suggesting that presynaptic 
function is not affected through decreased or absent levels of CX3CR1 
(Figure 4c; one-way ANOVA followed by Tukey’s post hoc: *, p<0.01).    
It has been shown that hippocampal slice preparations enhance 
microglial activation (Haynes, Hollopeter et al. 2006). Given the well-
characterized effects of CX3CR1 signaling in modulating microglial 
activation, it was important to examine the hippocampal slice 
preparations for baseline alterations in microglial activation and/or 
neurotoxicity between WT, Cx3cr1+/-, and Cx3cr1-/- genotypes.  DAPI 
staining showed no difference between genotype in microglia alteration 
and or neurotoxicity (data not shown) 
CX3CR1 deficient mice have increased microglial 
activation, hippocampal levels of IL-1b and p38 and cerebellar 
levels of TNFa. The IL-1 receptor antagonist, IL-1ra, is the naturally 
occurring receptor antagonist of IL-1b (Dinarello 1997; Rothwell, Allan 
et al. 1997).  Recently, we demonstrated in young rats that infusion of 
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IL-1ra completely reverses the decrease in hippocampal neurogenesis 
induced by the co-administration of CX3CR1 blocking antibody 
(Bachstetter, Morganti et al. 2009). Next, we wanted to determine if 
basal levels of hippocampal IL-1b were altered in CX3CR1-/- mice.   We 
analyzed the hippocampus of these mice for protein expression of IL-
1b.   Hippocampi from CX3CR1-/- and CX3CR1 +/- mice have increased 
IL-1b expression compared to wild-type mice (Figure 5a; One-way 
ANOVAs, p<0.01).    
The MAP kinase p38 is a key signal transduction factor involved 
in the production of IL-1b and TNFa (Guesdon, Freshney et al. 1993; 
Rouse, Cohen et al. 1994; Raingeaud, Gupta et al. 1995). Due to the 
importance of p38 in IL-1b signaling, we wanted to determine whether 
hippocampal levels of phospho-p38 were altered in CX3CR1 deficient 
mice.   Not surprisingly, phospho-p38 protein levels were significantly 
increased in the hippocampus of CX3CR1-/- and CX3CR1+/- mice when 
compared to wild-type mice (Figure 5b).  CX3CR1-/- mice have 
impaired motor learning that may represent cerebellar dysfunction.  
We next determined whether deficiencies in CX3CR1 affected 
cerebellar TNFa protein levels.  TNFa expression was significantly 
increased in CX3CR1-/- mice compared to wild-type (Fig 5c).  Taken 
together, CX3CR1 deficiency leads to increased expression of IL-1b, 
p38 and TNFa,  suggesting increased inflammation of the CNS. 
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Loss of CX3CR1 leads to over-activation of microglia following an 
insult.   To determine under basal conditions whether lack of CX3CR1 
receptor leads to increased activation of microglial cells, we 
immunostained hippocampal sections from CX3CR1 -/-, CX3CR1+/- 
and wild-type mice for Iba-1, a marker for both resting and activated 
microglia.  The area of Iba-1 staining is significant higher in CX3CR1-/- 
when compared to wild-type and CX3CR1+/- mice (Figure 5d, p < 
0.05, CX3CR1-/- vs wild-type), reflecting an increased volume of 
microglial cells reflective of morphology associated with activated 
microglia.   
IL-1ra recovered the LTP deficit of CX3CR1 deficient mice. 
Increased levels of IL-1b negatively modulate induction and 
maintenance of LTP (Cunningham, Murray et al. 1996; Kelly, Vereker 
et al. 2003).  Because mice lacking the CX3CR1 receptor have 
increased levels of IL-1b, we determined if the IL-1 receptor 
antagonist, IL-1ra, reverses the impairment in synaptic plasticity 
observed in the CX3CR1-/- mice.  To determine if IL-1ra can improve 
synaptic plasticity in CX3CR1 deficient mice, hippocampal slices were 
perfused with varying concentrations of IL-1ra and post-tetanic 
potentiation was induced.  In agreement with the LTP results, 
hippocampal slices from CX3CR1-/- mice had deficits in PTP compared 
to wild-type mice (Figure 6a).  However, when hippocampal slices 
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from CX3CR1-/- mice were perfused with 100 µg/ml of IL-1ra, the 
deficit in PTP was rescued (Figure 6a).  Blocking the function of IL-1b 
completely reversed the impairment in PTP.  Our observation that PTP 
in hippocampal slices from CX3CR1-/- was rescued with perfusion of IL-
1ra prompted us to determine if the long-lasting LTP deficit in CX3CR1-
/- mice could be rescued as well.  Perfusion of 100 µg/ml of IL-1ra to 
hippocampal slices from CX3CR1-/- completely rescued the deficit in 
LTP induction and maintenance (Figure 6b).  Taken together, these 
results suggest that the deficits seen in CX3CR1-/- are due to increased 
levels of IL-1b, further implicating a detrimental increase of 
inflammation in the CNS. 
 
IL-1ra reversed the deficit in hippocampal dependent 
cognitive function but not motor learning in CX3CR1 deficient 
mice. To determine whether the impairment in motor learning and 
cognitive function was also dependent on IL-1b , we performed a 
second study in which wild-type and CX3CR1-/- mice were infused with 
either IL-1ra, heat-inactivated IL-1ra, or ACSF.  In agreement with the 
first study, mice were tested starting from the least invasive task 
(open field) to the most invasive task; Morris water maze (McIlwain, 
Merriweather et al. 2001).   
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Open Field and Elevated Plus Maze.  Although in the first study 
there were no significant impairments in general locomotor activity, 
explorative behavior and anxiety levels of the CX3CR1 deficient mice 
and wild-type, it was crucial to retest the performance of new groups 
of mice, to exclude the possibility that the surgery procedure could 
impair general motor activity or enhance anxiety levels .  Wild-type 
mice infused with either ACSF (n = 11), heat-inactivated IL-1ra (n = 
12),IL-1ra (n = 11), and CX3CR1-/- infused with either ACSF (n = 14) 
or IL-1ra (n = 13)  were first tested in the open field behavioral task.   
Spontaneous locomotor activity was assessed as the total amount of 
distance traveled in the chamber.  As observed in the first study there 
were no significant differences between genotypes in total distance 
traveled.  Furthermore, no significant differences were observed 
between treatments (data not shown).  In addition, the distance 
traveled in the center zone compared to the perimeter zone and the 
time spent in each zone was similar between groups (data not shown).  
Anxiety levels were also measured using elevated-plus maze task.  
Their level of anxiety was determined by the amount of time spent 
exploring the open arms of the maze versus the time spent in the 
closed arms.  As previously shown, all groups spent similar amounts of 
time in the open arms and in the center zone compared to wild-type 
mice and no effect of IL-1ra was observed (data not shown).   
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Rotarod. Wild-type mice (ACSF, n = 11; heat-inactivated IL-
1ra,n = 12; IL-1ra, n = 11) and CX3CR1-/- (ACSF, n = 14; IL-1ra, n = 
13) were then tested on rotarod as described above.  No differences 
were observed between genotypes during the first day of training (Fig 
7A).  On the second day of training (trials 5-8), wild-type mice 
remained on the rod for longer periods of time compared to CX3CR1-/- 
mice.  However, neither CX3CR1-/- treated with IL-1ra or CX3CR1-/- 
control mice showed significantly improvement in motor coordination 
on the second day of training (Figure 7a; 2-way ANOVA, trial, 
p<0.0001; treatment, p<0.0001; interaction p= 0.69).  As 
demonstrated in the first study (Figure 2a), all wild-type mice 
performed significantly better on trial 8 compared to trial 1 than did 
CX3CR1-/- control group (Bonferroni posttest, WT ACSF, heat-inact.  
IL-1ra, WT IL-1ra vs CX3CR1-/- p< 0.05).  CX3CR1-/- IL-1ra - treated 
mice motor performance was not different from CX3CR1-/- control 
group (CX3CR1-/- vs CX3CR1-/-  IL-1ra,  p>0.05, data not shown), 
suggesting that IL-1ra does not modulate the motor learning 
impairment.  There were no significant differences on the first trial of 
testing between all experimental groups, which suggests that there is 
no difference in baseline motor skills (data not shown).  Taken 
together, these data suggest that IL-1b does not modulate the deficits 
in motor learning observed in the CX3CR1-/- mice.   
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Contextual Fear Conditioning. To address the role of IL-1b in the 
cognitive impairment observed in CX3CR1 deficient mice, we trained 
wild-type mice (3 subgroups: ACSF, heat-inactivated IL-1ra, IL-1ra) 
and CX3CR1-/- mice (2 subgroup: ACSF, IL-1ra) on contextual fear 
conditioning and auditory cue fear conditioning as described above.  
During training, all groups showed similar levels of freezing in 
response to the first and second pairing of tone and mild foot shock 
(Figure 7B).  This indicates that all groups have the capability of 
freezing and that the acquisition of fear memory is indistinguishable 
between the two groups.  When placed in the training context 24 
hours following training, CX3CR1-/- mice showed a significant reduction 
in the amount of freezing compared to wild-type mice (Figure 7c; 
p<0.0005; Bonferroni post-hoc = WT ACSF vs CX3CR1-/- p <  0.05; 
wild-type heat-inact.  IL-1ra vs CX3CR1-/- p < 0.001).  Interestingly, 
IL-1ra completely reversed the deficit in contextual memory in 
CX3CR1-/- mice (Bonferroni post-hoc = p< 0.001), suggesting that IL-
1b modulates the deficit in contextual memory due to the loss the loss 
of CX3CR1.  Wild-type mice treated with IL-1ra were not significantly 
different from CX3CR1-/- control or from wild-type controls.  In 
contrast, all groups exhibited identical responses to the presentation of 
the auditory CS when presented in a different context (data not 
shown).  These data suggest that IL-1b action is specific for 
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hippocampal-dependent cognitive function.  To control for possible 
differences in response to the foot shock, a shock threshold test was 
performed.  No differences were observed in the perception of the foot 
shock delivery as assessed by determining the stimulus amplitude 
necessary to evoke a flinching, jumping, or vocalization (data not 
shown). 
Morris water maze. Following the observation that IL-1 directly 
modulated the impairment in contextual memory in CX3CR1 deficient 
mice, we sought to determine if IL-1b also modulated the deficit 
previously observed in spatial learning (Figure 3).  To answer this 
question, 8 days following fear conditioning the same animals were 
trained to locate a submerged platform in a circular pool filled with 
opaque water as described in the first study, a probe trial was 
performed after 9 days of training matching the data shown from 
study 1.  No difference was observed between groups in the latencies 
to find the platform during training, indicating that all animals have 
normal acquisition of spatial information (Figure 7D).  We then 
analyzed memory retention with a probe trial where the platform was 
removed and mice were allowed to free swim.  CX3CR1 -/- control mice 
had a significant decrease in the number of target platform crossings 
during the probe trial compared to wild-type control mice (Figure 7e; 
Two-way ANOVA, P = <0.0001 followed by Bonferroni post-hoc: WT 
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ACSF, WT heat-inactivated IL-1ra vs CX3CR1-/- control p<0.05).  
Importantly IL-1ra was able to completely reverse the deficit in spatial 
memory observed in CX3CR1 deficient mice (CX3CR1-/- control vs 
CX3CR1-/- IL-1ra, p < 0.05).  No differences were observed between 
experimental groups on the visible platform test (data not shown).  In 
addition we analyzed the time spent in the target platform zone.  
CX3CR1-/- mice spent significantly less time in the target zone 
compared to wild-type control (Figure 7F, Two-way ANOVA, p<0.0001 
followed by Bonferroni post-hoc: wild-type ACSF, wild-type heat-
inactivated IL-1ra vs CX3CR1-/- control IL-1ra p<0.05).  CX3CR1-/- 
mice treated with IL-1ra spent the same amount of time in the target 
zone when compared to control (CX3CR1-/- control vs CX3CR1-/- IL-1ra 
p< 0.001).  No difference was observed in the number of crossing and 
in the time spent in the target quadrant between CX3CR1-/- control 
mice and wild type mice treated IL-1ra.  These data further support 
the role of the CX3CR1 receptor to modulate hippocampal-dependent 
learning and memory and that IL-1β modulates the impairment in 
hippocampus dependent cognitive function. 
 
DISCUSSION 
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For the first time the present studies test the hypothesis that 
CX3CL1signaling through CX3CR1 may be necessary for normal 
synaptic function.  We demonstrated a physiological role of the 
chemokine receptor CX3CR1 to regulate cognitive function and 
synaptic plasticity.  Furthermore, we show that genetic disruption of 
CX3CR1 impairs hippocampal neurogenesis, motor learning, 
associative memory, spatial memory, and the induction of LTP.  
Importantly, these deficits appear to be gene-dose dependent and 
related to increased levels of IL-1b. 
 These novel discoveries provide important insight to 
understanding the involvement of the CX3CR1 receptor under 
physiological conditions.  Previously, we showed that CX3CR1-/- mice 
have decrease hippocampal neurogenesis when compared to 
heterozygote littermates (Bachstetter, Morganti et al. 2009). We now 
demonstrate a gene-dose-dependent effect of CX3CR1 deficiency as 
demonstrated by heterozygous CX3CR1 mice that exhibit an 
intermediate phenotype.  This effect was observed in associative and 
spatial memory formation, which indicates that the loss of a single 
allele is sufficient to impair the receptor function.   
 Recently, a gene-dose effect of CX3CR1 receptor was reported 
that related to fibrillar Ab deposition in APP-PS1 mice crossed with 
CX3CR1-/-, CX3CR1+/- or CX3CR1+/+ (Lee, Varvel et al. 2010). 
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Reduction in fibrillar Aβ deposition in the APP-PS1 mouse model of AD 
was gene-dose dependent on CX3CR1 deficiency, with CX3CR1+/- mice 
displaying an intermediate phenotype.  The present studies are in 
agreement with those previous results and underscore the profound 
implication of this discovery toward interpretation of all previous 
studies using only CX3CR1-/- and CX3CR1+/- mice.   
 We report a novel physiological role for the CX3CR1 receptor in 
the regulation of hippocampal-dependent memory formation.  The 
impairment of LTP and neurogenesis likely represent the mechanism 
responsible for the defect observed in hippocampal-dependent 
associative and spatial memory formation.  However, multiple 
mechanisms can account for the impairment in cognitive function and 
synaptic plasticity observed in the CX3CR1-defient mice. 
 CX3CL1 has been implicated as a endogenous neuronal 
modulator, which controls the over-production of iNOS, IL-1β, TNFα 
and IL-6(Biber, Neumann et al. 2007).  CX3CL1 levels are down-
regulated with neuronal injury, which results in microglial recruitment, 
activation and increase production of TNFa, IL-1b and p38 MAP kinase.  
IL-1b is a pro-inflammatory cytokine, which is constitutively expressed 
in the CNS, particularly in the hippocampus, and is synthesized by 
neurons and glial cells following neuronal injury (Rothwell, Allan et al. 
1997; Dinarello 1998). Binding studies demonstrate that the 
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hippocampus contains the highest density of IL-1b binding sites 
(Farrar, Kilian et al. 1987; Takao, Tracey et al. 1990). These findings 
suggest that the effects of IL-1β might be specific to hippocampus, 
which may affect hippocampal-dependent learning and memory 
processes.  Furthermore, there may be a causal relationship between 
the decrease of LTP and increase of IL-1β expression.   
 In the present study, we demonstrate that hippocampal protein 
levels of IL-1b and phospho-p38 are significantly increased in mice 
lacking CX3CR1 receptor.  This increase was accompanied by a change 
in morphology, consistent with the activation of hippocampal microglia 
cells, observed as increased area of Iba-1 staining.  Furthermore, the 
increase of these protein levels was accompanied by a decrease in LTP 
in CX3CR1 deficient mice.  The deficit in LTP was gene-dose 
dependent, with CX3CR1+/- mice that demonstrate an intermediate 
phenotype.  Importantly, both the deficits in LTP and cognitive 
function were rescued with administration of IL-1ra, which blocked the 
IL-1 receptor I.  Under physiologic circumstances IL-1β seems to be 
required for normal learning and memory processes.  This assertion 
derived from the observation that mice with targeted deletion of IL-1RI 
exhibit impairments in memory and synaptic plasticity (Hirsch, Irikura 
et al. 1996).  Similarly, the administration of IL-1ra impairs fear-
conditioning (Pugh, Nguyen et al. 1999; Rachal Pugh, Fleshner et al. 
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2001) and performance in the Morris water maze in young rats (Avital, 
Goshen et al. 2003). In agreement with the literature, our results 
show that wild-type mice treated with IL-1ra are not different from 
CX3CR1-/- deficient mice in the response to contextual freezing and 
Morris water maze task.  Thus, physiologic levels of IL-1β might be 
critical for normal memory formation in the hippocampus and the 
increased IL-1β levels observed with age might impair hippocampal-
dependent learning and memory.   
 In addition to the impairment of memory function, CX3CR1-
deficient mice have impairments in motor learning.  Interesting, 
cerebellar levels of TNFa were significantly increased in mice lacking 
CX3CR1 receptor.  This result is in agreement with previous reports 
that show TNFα modulates age-dependent deficits in motor learning 
(Cartford, Gemma et al. 2002). Also, we demonstrate an important, 
physiological role of the CX3CR1 receptor in normal memory formation 
and synaptic plasticity.  Furthermore, our results demonstrated that 
disruption of CX3CR1 signaling triggers a downstream increase in IL-
1b, which appear to be the key modulator responsible for the 
detrimental effect of loss of CX3CL1/CX3CR1 signaling on cognitive 
function.   
 We clearly demonstrate that under non-pathological conditions, 
disruption of CX3CL1/CX3CR1 signaling results in increased expression 
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of IL-1b and p38, which is accompanied by the loss of synaptic 
plasticity and memory formation.  Furthermore, these effects appear 
to be gene-dose dependent.  This observation needs to be considered 
when interpreting data associated with disease conditions or under 
conditions where heterozygous mice were used as controls for 
CX3CR1-/- mice.  However, this discovery does not negate all of the 
important findings to date with regard to the role of CX3CR1/CX3CL1 
signaling in many disease conditions.   
 There is substantial literature in the area of CX3CR1/CX3CL1 
signaling, yet no consensus to the role of this pathway as either 
neuroprotective or neurodegenerative has been agreed upon.   In AD 
mouse models, CX3CR1-/- microglia have increased phagocytosis, 
which helps to clear Aβ (Lee, Varvel et al. 2010).  Deletion of the 
CX3CR1 gene in a triple transgenic (3xTg) mouse model of AD is 
protective against neuronal loss(Fuhrmann, Bittner et al. 2010).  
However, CX3CR1-deficient 3xTg mice were examined at an age prior 
to the development of either extracellular Ab deposition or intracellular 
microtubule-associated protein tau (MAPT) aggregation.  Furthermore, 
CX3CR1-/- mice crossed with the AD mouse model CRND8 had lower 
brain levels of Ab40 and Ab42 and reduced amyloid deposits, which 
are related to increased microglia proliferation and phagocytosis (Liu, 
Lu et al. 2010).  Finally, CX3CR1-/- mice crossed with mice 
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overexpressing hTau have increased hyperphosphorylated tau and 
increased toxicity, likely related to the increase p38 and IL-1β 
(Bhaskar, Konerth et al. 2010) expression.  Taken together, the 
mechanisms that underlie CX3CR1 signaling which lead to 
neurotoxicity remains unclear.  In conclusion, this study demonstrated 
that CX3CR1 receptors play a physiological role in normal 
hippocampal-dependent cognitive function and synaptic plasticity.  In 
addition, the present study provides mechanistic links between 
CX3CR1 and the release of IL-1b and phospho-p38, ultimately 
implicating an increase in inflammation with the deficits observed in 
synaptic plasticity and cognition. 
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Figure 1.  CX3CR1-/- mice show decreased hippocampal neurogenesis in a 
gene-dose dependent manner (a, b).  Unbiased stereology revealed a significant 
decrease in the number of DCX+ cells in the SGZ of adult male CX3CR1-/- and 
CX3CR1+/- mice compared to wild-type mice (p< 0.001).  CX3CR1-/- were also 
significantly different from CX3CR1+/- (p<0.05) (a).  Quantification of the number 
of cells that were proliferating during the preceeding 24 hours as determined by 
the incorporation of BrdU, was significantly fewer in the CX3CR1-/- and 
CX3CR1+/- mice compared to wild-type (p<0.001).  CX3CR1-/- were also 
significantly different from CX3CR1+/- (p<0.05) (b).  Wild-type (WT, white bar), 
CX3CR1+/- (gray bar), CX3CR1-/- (black bar).  All data are presented as mean ± 
SEM p < 0.01 
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Figure 2.   
CX3CR1-/- and CX3CR1+/- mice show motor learning impairment but normal 
spontaneous activity (a, b, c).  On the first day of training (trial 1-4) no difference 
between genotypes was observed in the learning ability in the rotarod task (a).  
On the second day of training (trials 5-8) as expected, wild-type mice learned the 
rotarod task as demonstrated by their ability to remain on the rod for longer 
periods.  Neither the CX3CR1-/- nor the CX3CR1+/- mice showed significant 
improvement in motor coordination with training when compared to wild-type (a; 
Repeated Measure ANOVA, p<0.0001.).  Wild-type (WT, white circles), 
CX3CR1+/- (gray circles), CX3CR1-/- (black circles).  All data are presented as 
mean ± SEM p < 0.01.  Comparison of the motor performance of each group of 
mice on trial 1 versus trial 8, show that wild-type performed significantly better 
than CX3CR1-/- and CX3CR1+/- (b; linear regression, p<0.001).  CX3CR1 -/- and 
CX3CR1+/- mice show normal spontaneous locomotor activity (c).  Wild-type, 
CX3CR1-/- and CX3CR1+/- mice do not show any difference in total distance 
traveled in the open field (c).  Wild-type (WT, white bar), CX3CR1+/- (gray bar), 
CX3CR1-/- (black bar).  All data are presented as mean ± SEM p < 0.01 
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Figure 3.  CX3CR1-/- mice show impairment in contextual fear conditioning and 
Morris water maze memory function.  CX3CR1-/- (black circles) and CX3CR1+/- 
(gray circles) are compared to littermate wild-type mice (white circles).  In panel 
A, a tone (solid bar) was paired with a foot shock (arrowhead) at 2 and 4 
minutes.  Freezing behavior is shown on the day of training for CX3CR1-/-, 
CX3CR1+/- and wild-type (a) and is comparable in all groups.  CX3CR1-/-, 
CX3CR1+/- showed significant reduced freezing response compared to wild-type, 
when tested 24 h following training (b).  CX3CR1-/-, CX3CR1+/- showed normal 
freezing to cue component compared to controls (c).  Asterisks represent p<0.01.   
Panels d and e show the hidden platform version of Morris water maze task.   
Mean latency to escape from a pool to hidden platform across training days (d).   
A first probe test was performed on day 7 and a second probe test was 
performed on day 11 (e) to determine the number of pseudo platform crossings 
in the target quadrant (TQ) compared to the opposite quadrant (OP), the left 
quadrant (LQ) and the right quadrant (RQ).   Wild type (WT, white bar), 
CX3CR1+/- (gray bar), CX3CR1-/- (black bar).  All data are presented as mean ± 
SEM p < 0.01.   All data are presented as mean ± SEM p < 0.01 
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Figure 4.   CX3CR1 deficiency leads to impairments in LTP.  LTP was induced 
with HFS (2, 1 sec, 100 Hz bursts separated by 20 s; arrow) after 20 min of 
baseline recording and changes in fEPSP slope are expressed as a percentage 
of baseline (a).  Representative fEPSP traces taken from hippocampal slices of 
(left to right) wild-type, CX3CR1+/- and CX3CR1-/- mice (b).   Both CX3CR1-/- 
(black) and CX3CR1+/- (red) have deficiencies in LTP of area CA1 compared to 
wild-type controls (white) (c).   The last 5 min of fEPSPs slope recordings were 
averaged for wild-type (n=12), CX3CR1-/- (n=10) and CX3CR1+/- (n=9) mice 
(Asterisks represent p<0.05.) (d).  Paired-pulse facilitation (PPF) was induced 
with the use of paired- pulses given with an initial delay of 20 ms and the time to 
the second pulse was increased 20 ms incrementally until a final delay of 300 ms 
was reached.  There was no significant PPF differences between experimental 
groups.   All data are presented as mean ± S.E p < 0.01 
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Figure 5.   CX3CR1 -/- and CX3CR1+/-  show increased hippocampal protein 
levels of  IL-1β compared to littermate wild-type (WT) as measured by ELISA (a).   
Western blot analysis of hippocampi from wild-type , CX3CR1-/- and CX3CR1+/- 
mice shows an increase in phospho (p) p-38 protein in CX3CR1-/- and CX3CR1+/- 
mice compared to that of wild-type (right blot in b; near-infrared image displayed 
in gray scale).  Relative p p-38 expression normalized to β-actin, shows the 
highest expression in CX3CR1-/- and CX3CR1+/- (b).   TNFα cerebellar protein 
levels are significantly increased in CX3CR1-/- and CX3CR1+/- mice as compared 
to wild-type mice as measured by ELISA (c).  The area of Iba-1 staining  is 
significant higher in CX3CR1-/- when compared to wild-type and CX3CR1+/- as 
measured by immunohistochemistry (d).   Wild-type (WT, white bar), CX3CR1+/- 
(gray bar), CX3CR1-/- (black bar).   Representative photomicrographs of the Iba-
1+ cells in the dentate gyrus of wild-type (e) and CX3CR1 deficient mice (f).  All 
data are presented as mean ± SEM p < 0.01.   Asterisk represents p < 0.05 
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Figure 6.   CX3CR1 deficiency leads to impairments in synaptic plasticity which 
are rescued through IL-1β antagonism.  PTP was induced with HFS (1 sec, 100 
Hz bursts; arrow) after 1 min of baseline recording.  LTP was induced with HFS 
(2, 1 sec, 100 Hz bursts separated by 20 s; arrow) after 20 min of baseline 
recording.   Changes in fEPSP slope are expressed as a percentage of baseline 
(a).  The IL-1β antagonist, IL-1ra (100 µg/ml) rescues the PTP deficit (red, n=7) 
in hippocampi taken from CX3CR1-/- (black, n=8) in area CA1 to levels seen in 
wild-type (white, n=9).  (b.) The LTP deficit seen in hippocampi taken from 
CX3CR1-/- (black, n=10) mice is rescued with the IL-1β antagonist IL-1ra (100 
µg/ml) (red, n=11).   
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Figure 7.   IL-1ra reversed the deficit in contextual fear conditioning and Morris 
water maze memory function induced by the loss of CX3CR1 but not the deficit in 
motor learning. CX3CR1-/- ACSF(blue square) and CX3CR1-/- IL-1ra - treated 
mice (red square) are compared to wild-type ACSF (open circles), wild-type 
treated with heat-inactivated IL-1ra (black square), and wild-type IL-1ra-treated 
mice (green squares).   Panel A shows that on the first day of training (trial 1-4) 
no difference between groups was observed in the learning ability on the rotarod 
task (a).   On the second day of training (trials 5-8) all wild-type mice groups 
learned the rotarod task as demonstrated by their ability to remain on the rod for 
longer periods.   Neither the CX3CR1-/- ACSF nor the CX3CR1-/- IL-1ra treated 
mice showed significant improvement in motor coordination with training when 
compared to wild-type (a);.  In panel B, a tone (solid bar) was paired with a foot 
shock (arrowhead) at 2 and 4 minutes.   Freezing behavior is shown on the day 
of training for CX3CR1-/- ACSF (blue square), CX3CR1-/- IL-1ra – treated mice 
(red square), wild-type ACSF (white circles), wild-type treated with heat-
inactivated IL-1ra (black square), and wild-type IL-1ra treated mice (green 
square) and is comparable in all groups.   CX3CR1-/- control mice showed 
significantly reduced freezing compared to all wild-type groups, when tested 24 h 
following training (c).  CX3CR1-/- treated with IL-1ra (red square) showed a 
freezing response similar to wild type groups.  Panels d and e and f show the 
hidden platform version of Morris water maze task.   Mean latency to escape 
from a pool to hidden platform across training days (d).   A probe test was 
performed on day 10 to determine the number of pseudo platform crossings in 
the target quadrant (TQ) compared to the opposite quadrant (OP) (e).  Wild type 
ACSF (WT, white bar), wild-type treated with heat-inactivated IL-1ra (light gray 
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bar), wild-type treated with IL-1ra (dark gray bar), CX3CR1-/-  ACSF (black bar), 
CX3CR1-/- IL-1ra – treated mice (black/white grid bar).   Panel F shows the time 
spent in the target platform zone.   CX3CR1-/- ACSF (black bar) mice spent 
significantly less time in the target zone compared to wild-type controls (wild-type 
ACSF (white bar), wild-type heat-inactivated IL-1ra (light gray bar), wild-type IL-
1ra (dark gray bar).  CX3CR1-/- mice treated with IL-1ra spent the same amount 
of time in the target quadrant when compared to wild-type controls.  All data are 
presented as mean ± SEM p < 0.01.   All data are presented as mean ± SEM p < 
0.01  Asterisk represents p < 0.05: CX3CR1-/- control vs wild-type controls;   ## 
represents p<0.001: CX3CR1-/- IL-1ra vs CX3CR1 -/-.    
!!
59!
 
 
 
Chronic LPS induced disruption of CX3CL1 signaling is 
associated with hippocampal dependent cognitive dysfunction. 
Josh M. Morganti1#, Karim Belarbi2,3#, Sonali Ranjit5, Carla Arellano2, 
Carmelina Gemma1,6, Paula C. Bickford1,6, and Susanna Rosi2,3,4* 
1Department of Neurosurgery, Center of Excellence for Aging and Brain 
Repair, University of South Florida, College of Medicine, Tampa, FL. 
2Brain and Spinal Injury Center, Departments of Physical Therapy 
Rehabilitation Science3 and 4Neurological Surgery, 5Honors College, 
University of South Florida, Tampa, FL., 6James A. Haley VAMC, 
Research Service, Tampa, FL. 
Abstract 
Chronic neuroinflammation is characterized by activation of the 
innate immune system and it is an important element common to 
many neurological and pathological conditions associated with memory 
loss and cognitive dysfunctions. Activated microglia and their products 
are key mediators of neuroinflammation and contribute to neuronal 
damage. Neuroinflammation can be reproduced by chronically infusing 
lipopolysaccharide (LPS) into the 4th ventricle of rats resulting in region 
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selective microglia activation in the hippocampus, and impaired 
hippocampal dependent functions. Recent findings indicate that 
neurons are not passive targets, but rather control microglial activity 
and modulate neuron-glia communications.  The chemokine fractalkine 
(CX3CL1) is a neuronally derived signal that has been shown to 
regulate the neurotoxic effects of microglia though its receptor 
CX3CR1.  We recently demonstrated that CX3CR1 has a physiological 
role in normal hippocampal-dependent cognitive function and synaptic 
plasticity. Disruption of CX3CL1-CX3CR1 signaling has been shown to 
exacerbate neurotoxicity in animal models of many neuropathological 
disorders including AD. In the present study we investigated if chronic 
inflammation alters neuron to microglia signaling via the CX3CL1-
CX3CR1 signaling pathway.  Rats were chronically infused for 28 days 
with LPS (0.25ug/h) or artificial cerebrospinal fluid (aCSF). On day 31 
animals were tested for spatial and object recognition memory. LPS-
induced chronic neuroinflammation resulted in impairment of novel 
place recognition but not of novel object recognition memory. Analysis 
of hippocampus protein lysates revealed a significant reduction in the 
amount of CX3CR1 protein levels in LPS infused animals compared to 
aCSF controls with no significant changes in CX3CL1 levels. The LPS-
induced reduction in hippocampal CX3CR1 paralleled a significant 
induction of classical microglial activation markers TNF-α, Notch1, NF-
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kB p65 as well as the co-receptor for LPS; TLR4. Together these 
studies demonstrate that altered microglia signaling through CX3CL1-
CX3CR1 is involved in the modulation of LPS-induced chronic 
neuroinflammation in the hippocampus. The CX3CL1-CX3CR1 signaling 
pathway may mediate the altered coupling of neuronal activity with 
macromolecular synthesis implicated in plasticity and memory during 
LPS-induced neuroinflammation. 
 
Introduction 
Numerous neuropathology and in vivo clinical imaging studies 
suggest that activated microglia play a prominent role in the 
pathogenesis of several neurodegenerative disorders such as 
Alzheimer’s disease (AD), Parkinson disease and immune mediated 
neurological disorders (HIV) (McGeer and McGeer 1998; Cagnin, 
Brooks et al. 2001; Garden, Guo et al. 2004). Microglial cells are the 
resident innate immune effectors of the brain and react to various 
"insults", such as abnormally aggregated proteins, viruses, bacteria, 
physical injury or signaling molecules released by neurons though 
activation of Toll-like receptors (TLRs).  Activated microglia are a 
prominent source of pro-inflammatory cytokines, chemokines, reactive 
oxygen species and complement proteins (Mantovani, Sica et al. 2004; 
Mosser and Zhang 2008; Cameron and Landreth 2010). While 
microglia activation is normally adaptative, uncontrolled and over-
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activated microglia can lead to bystander damage to neurons. 
Chronically activated microglia and their products are key mediators of 
the neuroinflammatory cascade, which may lead to neuronal 
dysfunction (Barger and Basile 2001). 
Recent data has begun to establish CX3C- chemokine fractalkine 
(CX3CL1) to fractalkine receptor (CX3CR1) interactions as an 
important mechanism of microglial regulation, hippocampal functions 
and synaptic plasticity (Harrison, Jiang et al. 1998; Mizutani, Sakurai 
et al. 2007; Bachstetter, Morganti et al. 2009; Wynne, Henry et al. 
2010; Pabon, Bachstetter et al. 2011; Rogers, Morganti et al. 2011). 
CX3CL1 is constitutively expressed by neurons in the CNS with 
CX3CR1 found solely on microglia (Harrison, Jiang et al. 1998; 
Maciejewski-Lenoir, Chen et al. 1999; Boehme, Lio et al. 2000; 
Cardona, Pioro et al. 2006). This signaling pair presents the unique 
ability for neurons to directly interact with microglia. In vivo 
neutralization of endogenous brain CX3CL1 increases hippocampal 
Tumor Necrosis Factor (TNF)-〈 induced by intracerebroventricular 
(i.c.v.) injection of lipopolysaccharide (LPS) (Zujovic, Schussler et al. 
2001) and CX3CR1-deficiency amplifies microglial IL-1ß expression, 
neurotoxicity, and mortality following peripheral LPS injections 
(Cardona, Pioro et al. 2006). Though CX3CL1-CX3CR1 likely 
represents a critical element of microglia regulation, little is known 
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about how this pathway is altered during chronic neuroninflammation.  
In the present study, we aimed to assess to what extent CX3CL1 
and CX3CR1 expressions were impacted in a well-established rodent 
model of LPS-induced chronic neuroinflammation. We demonstrate 
that at a time point where spatial cognitive function is impaired, 
CX3CR1 but not CX3CL1 expression level was significantly decreased 
in the hippocampus. This decrease was closely associated with 
markers of classical microglia activation and occurred only in the 
hippocampus but not in the prefrontal cortex. 
 
Materials and Methods 
 Animal procedures. This research was conducted under the 
supervision and with the approval of the University of California 
Institutional Animal Care and Use Committee. Twelve 3-month-old 
male F344 rats (Charles River Labs) living in an inverted 12-hour 
light/dark cycle (lights off at 8 a.m. and on at 8 p.m.) were individually 
caged with food and water freely available. Surgeries were performed 
as previously described in details (Rosi, Ramirez-Amaya et al. 2005). 
Artificial cerebrospinal fluid (aCSF; n=6) or lipopolysaccharide (LPS; 
n=6; Sigma-Aldrich, E.coli, serotype 055:B5, TCA extraction, 1.0 µg/µl 
dissolved in aCSF) were loaded into an osmotic pump (Alzet pump 
model 2004; to deliver 0.25 ul/h; 28-day delivery; Durect corporation) 
and chronically infused for 28 days through a cannula implanted into 
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the fourth ventricle of the brain as described previously (Rosi, 
Ramirez-Amaya et al. 2005). 
 
 Behavioral testing. The rats were handled daily for 10 days 
before behavioral testing began and behavioral manipulations were 
carried during the dark phase. A 60 cm square open field plastic arena 
was placed in a dim lit dedicated behavioral testing room. Various 
large extramaze spatial cues were placed on the walls of the testing 
rooms. Three sets of objects (A, B and C,) were used (Fig. 8). Small 
pieces of white Velcro placed on the undersides of the objects and on 
the arena floor were used to secure the objects in place during testing. 
Arenas and objects were cleaned with diluted bleach between trials to 
minimize odor cues. The procedure began with 2 days of habituation, 
during which rats were allowed to explore the open field arena for 
15 min. On day three, two similar objects A were placed in opposite 
corners of the box, and the rats were allowed to explore the objects 
for 5 min. The rats were removed from the box for 5 min, and for the 
5 min retention novel place recognition (NPR) test, one of the objects 
was moved to a new open corner (target object), and the rats were 
allowed to explore for 5 min. On day 4, a 24 h retention NPR test was 
conducted. The target object was moved to the remaining open corner 
and the rats were allowed to explore for another 5 min. For the novel 
object recognition (NOR) task, two objects B were placed in the 
!!
65!
corners not used for the 24h NPR test, and the rats were allowed to 
explore the objects for 5 min. The rats were again removed from the 
box for 5 min, and one of the objects was replaced with a novel object 
C (target object), and the rats were allowed to explore for another 
5 min. An overhead camera recorded the trials and live tracking of the 
animals was achieved using an automated video tracking system that 
discriminates tail to nose recognition (Ethovision XT; Noldus 
Information Technology). Exploratory behavior defined as the animal 
directing its nose toward an object at a distance within a 4-cm radius 
was analyzed during the first 30 sec on each test. Data are expressed 
as the percent time spent exploring the target object ([time exploring 
target]/[time exploring target + time exploring non-target object] x 
100), where the re-located object during the place recognition task 
and the novel object during the object recognition task represent the 
target object. 
 
 Brain Extractions and Protein Analysis. Animals were 
euthanized by deep isoflurane anesthesia followed by decapitation, the 
brain were quickly removed and the hippocampus and prefrontal 
cortex dissected and immediately frozen in -70 °C isopentane (Sigma-
Aldrich) for protein extraction. Hippocampal and cortical tissues from 
one brain hemisphere were homogenized using an electric tissue 
homogenizer in 1:10 weight to volume ratio of ice-cold RIPA buffer 
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(Millipore) containing protease inhibitors and EDTA (Pierce). Following 
homogenization, sample lysates were centrifuged at 10,000 x g at 4ºC 
for 15 minutes, the cleared supernatant was collected. Total protein 
content was measured using standard BCA assay (Pierce). For Western 
blot Analysis; 50 µg of total protein per lane was loaded onto a 10% 
SDS-polyacrylamide gel for electrophoresis. Proteins were transferred 
onto a nitrocellulose membrane for immunodetection. The membrane 
was blocked for 1-hour in 5% NFDM in PBS-Tween20 (PBST, 0.1%). 
Primary antibody incubations for CX3CR1 (Abcam, 1:1000), TLR4 
(Abcam 1:1000), NF-kBp65 (AbCam; 1:500), Notch1 (Invitrogen; 
1:1000), and Actin (Sigma; 1:3000) occurred overnight at 4ºC in 1% 
NFDM in PBST. Following washes in PBST, membranes were incubated 
simulateneously with anti-rabbit and anti-mouse secondary antibodies 
(LiCor; 1:5000) for 1-hour at room temperature in 1% NFDM in PBST. 
Following washes in PBST, membranes were scanned using LiCor 
Odyssey scanner and intensity for each band was measured using 
LiCor Odyssey image analysis software. For ELISA analyses, total 
CX3CL1 and TNF-〈 were assayed following manufacturer’s suggested 
protocol (RayBiotech; Norcross, GA). 
 
 Statistical Analysis. Statistical analysis was performed with the 
GraphPad Prism software version 5.0, using the Student’s t-test or 
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one-way ANOVA followed by a post-hoc Newman-Keuls multiple 
comparison test. Results are expressed as mean ± SEM and p<0.05 is 
considered significant for all tests. 
 
 
 
 
Results 
 Chronic LPS-infusion impairs spatial recognition but not 
objects recognition memory. Hippocampal-dependent spatial 
recognition memory was tested with the novel place recognition (NPR) 
test with 5min and 24h delay. Low dose LPS infusion did not impair 
mobility, as both aCSF and LPS infused rats explored similarly (Fig. 9a) 
In the 5 min retention NPR test (Fig. 9b), the control aCSF-infused rats 
spent a higher percent time exploring the object in the novel location 
than the one in the familiar location (64.71 ± 9.21 %; p=0.04). In 
contrast, LPS-infused animals spent a similar time exploring the object 
that had changed position  (45.57 ± 9.39) and the object that had 
remained in a constant position (p=0.52). Similar observation were 
made in the 24 h retention NPR test (Fig. 9c), where aCSF-infused rats 
spent a significantly higher percentage of time exploring the object in 
the novel location (75.16 ± 12.39 %) than that in the familiar location 
(p=0.01) whereas LPS-infused animals did not (55.40 ± 14.01 %; 
p=0.59). Recognition memory for objects, known not to depend 
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strictly on the hippocampus (Mumby, Gaskin et al. 2002), was 
measured with novel object recognition test (NOR). In the NOR test, 
both aCSF- and LPS-infused rats showed significant discrimination 
between the novel and familiar objects (Fig. 9d), spending significantly 
a higher percentage of time exploring the novel than the familiar 
object (92.82 ± 3.864 and 89.75 ± 4.511, respectively; p<0.0001 vs. 
familiar object for both). 
 Chronic LPS-infusion results in decreased CX3CR1 levels 
and increased classical activation of microglia markers in the 
hippocampus. As the CX3CL1 signaling axis has been implicated in 
attenuating the pro-inflammatory response following exposure to LPS, 
we examined how the protein levels of both CX3CL1 and CX3CR1 were 
affected in response to chronic i.c.v. infusion of LPS. Chronic i.c.v. 
infusion of low doses of LPS for 28 days resulted in a significant 
decrease in CX3CR1 protein levels in the hippocampus compared to 
aCSF-infused animals (Fig. 10a; p=0.006). Regardless of the 
treatment, aCSF or LPS, the total CX3CL1 (soluble and membrane) 
levels remained unchanged (Fig. 10c). Interestingly, the reduction on 
CX3CR1 was observed only in the hippocampus but not the prefrontal 
cortex (Fig. 10d). Chronic LPS-infusion resulted in a significant up-
regulation of the proinflammatory cytokine TNF-〈 in the hippocampus 
(p=.004, Fig. 11a) but not in the prefrontal cortex (Fig. 11b). 
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Furthermore, Notch1 a marker for classical activation in microglia, was 
significantly up-regulated in lysate from hippocampal (p=.0008, Fig. 
11c) but not prefrontal cortical (Fig. 11d) tissue. Exposure to chronic 
i.c.v. low doses of LPS also upregulated the production of LPS 
coreceptor TLR4 in the hippocampus compared to infusion with aCSF 
(p=0.01) but no difference was observed in PFC (Fig 12a, b). A similar 
change, after chronic LPS-infusion, was observed with the intracellular 
transcription factor Nuclear Factor kappa B, only in the hippocampus 
(NF-%B p65, p=0.005; Fig. 12c, d). 
 
Discussion 
In the present study we demonstrated that during chronic 
neuroinflammation there is a significant reduction in the microglial 
fractalkine receptor CX3CR1 in the hippocampus. These changes are 
paralleled by classical activation of microglia only in the hippocampus 
and impaired spatial dependent recognition memory. To the authors’ 
best knowledge this is the first report of alterations in the protein 
levels of CX3CR1 in the hippocampus under chronic neuroinflammatory 
conditions.  
Fractalkine is a unique chemokine that plays an important role in 
mediating neural–microglial interaction. A balanced signaling in the 
CX3CL1 to CX3CR1 pathway is necessary to keep microglia in a non-
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inflammatory state (Cardona, Pioro et al.). Inhibition of CX3CR1 has 
been shown to increase microglia activation and production of 
proinflammatory cytokines in CX3CR1 deficient mice (Cardona, Pioro et 
al. ; Bachstetter, Morganti et al.). CX3CL1 to CX3CR1 ligation acts as 
an endogenous calming signal for microglia and disruption of this 
pathway is exacerbates in multiple pathological models (Bhaskar, 
Konerth et al.), and in humans (Combadière, Feumi et al.).  
Administration of exogenous CX3CL1 has been shown to reduce the 
LPS-induced production of pro-inflammatory cytokines (IL-1β, IL-6, 
TNF〈) and nitric oxide in vitro, as well as preventing cytokine induced 
neuronal cell death (Zujovic, Benavides et al. 2000; Zujovic, Schussler 
et al. 2001; Mizuno, Kawanokuchi et al. 2003). Given the anti-
inflammatory capabilities of CX3CL1 in an LPS model of inflammation, 
we investigated if chronic exposure to LPS affected CX3CL1-CX3CR1 
signaling. Here we show that during chronic neuroinflammation, while 
the level of the CX3CL1 remains unchanged regardless of the brain 
region the microglial CX3CR1 levels are reduced only in the 
hippocampus. These data corroborate a previous report wherein acute 
peripheral administration of LPS in mice does not alter the 
hippocampal levels of CX3CL1 (Wynne, Henry et al.). The reduced 
levels of CX3CR1 found in this study were paralleled by increased in 
the proinflammatory cytokine TNF-alpha. These data are in agreement 
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with previous data showing that CX3CR1 KO mice showed elevated 
levels of proinflammatory cytokines (Rogers, Morganti et al. 2011) 
however it remains unclear whether the increases in TNF could drive 
the changes in CX3CR1 or vice versa. Furthermore, these data 
corroborate findings where LPS reduced CX3CR1 both transcript and 
surface expression levels from isolated microglia (Kremlev and Palmer 
; Wynne, Henry et al.).  
Animals infused with LPS performed significantly worse than 
animals infused with aCSF in NPR. Interestingly, no impairment was 
observed in NOR task regardless of either infusion, as both treatments 
displayed significant preference for NO. The spatial dependent 
recognition memory task is primarily hippocampal dependent (Morris, 
Garrud et al. 1982; Mumby, Gaskin et al. 2002; Barker and Warburton 
2011), while the object recognition memory test does not rely 
principally in hippocampal functioning (Aggleton and Brown 1999; 
Mumby, Gaskin et al. 2002). Interestingly, the lack of impairment in 
NOR is associated also with the lack of inflammatory induction 
detected in tissue outside the hippocampus. These data show that the 
hippocampus is the most vulnerable region to LPS-insult. The high 
vulnerability of the hippocampus versus other brain regions could be 
due to different reasons. Given that LPS acts through microglia TLR4 
receptors it could be either that the distribution of TLR4 in the 
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hippocampus is more concentrated or that once initiated, the 
inflammatory process in the hippocampus cannot resolve with time. 
The CX3CL1 signaling axis has been shown to modulate glutamitergic 
signaling (Deiva, Geeraerts et al. 2004), it is possible that the 
reduction in CX3CR1 protein alters this function, which results in 
neuronal dysfunction.  
 The LPS co-receptor TLR4, was markedly increased in the 
hippocampus of LPS-infused animals but not the PFC. Further 
suggesting that given a general insult, such as i.c.v. LPS infusion, the 
hippocampus is the most sensitive region. Accordingly, recent work 
has shown that TLR4 is upregulated in the hippocampus of patients 
with AD (Walter, Letiembre et al. 2007; Letiembre, Liu et al. 2009). 
Additionally, LPS-infusion induced the classical activation of microglia, 
in that we saw an increased expression of pro-inflammatory molecules 
in LPS-infused rats compared to those that received aCSF. LPS-infused 
animals showed a marked induction of Notch1, NFkB, and TNF〈. LPS 
has been previously shown to induce the expression of NFkB (Rosi, 
Ramirez-Amaya et al.). Further, multiple studies have linked the 
increase expression and nuclear translocation of NFkB with the Notch1 
signaling pathway (Monsalve, Ruiz-García et al. 2009; Morga, Mouad-
Amazzal et al. 2009). It is important to note that a previous report 
indicated that antibody blockade of Notch1 receptor had little effect on 
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LPS-induced TNF〈 production (Cao, Lu et al. 2008). Conversely, this 
study only examined the effect of acute LPS exposure, while another 
study has implicated exposure of TNF〈 in the induction of Notch1 
receptor expression in microglia (Grandbarbe, Michelucci et al. 2007). 
Notch1 signaling may indirectly participate with the induction of TNF〈 
in response to chronic exposure to LPS.  Our data are consistent with 
these pathways being at least indirectly involved in chronic LPS 
induced inflammation that results in hippocampal dependent cognitive 
deficits. Taken together, it is plausible that the chronic i.c.v LPS 
exposure induction of Notch1 results in increased NFkB 
phosphorylation and translocation to the nucleus, which in turn 
mediates TNF gene expression.  
 These data further support the strong correlation between the 
presence of inflammation and altered neuronal function. As we 
observed a distinct hippocampal related cognitive impairment as a 
result from our experimental paradigm, we sought to identify key 
mediators that may contribute to this cognitive dysfunction. We have 
previously shown that LPS-infusion into the fourth ventricle induces 
MHC II reactive microglia in the hippocampus of young rats (Rosi, 
Ramirez-Amaya et al. 2005; Rosi, Vazdarjanova et al. 2006) and 
impair learning and memory functions. Here we demonstrated that the 
presence of inflammatory markers solely in the hippocampus is also 
!!
74!
associated with strictly hippocampal dependent cognitive dysfunctions. 
 We have previously demonstrated that under non-pathological 
conditions, disruption of CX3CL1 signaling pathway leads not only to 
an increased basal inflammatory profile, but also negatively alters 
cognitive function (Rogers, Morganti et al. 2011). As such, it is 
therefore conceivable to hypothesize that altered neuron-to microglia 
signaling could contribute to the altered cognitive functions observed 
in chronic inflammatory conditions as well.   
As the CX3CL1-CX3CR1 signaling pair work in tandem to reduce the 
production of pro-inflammatory mediators, it is plausible that 
prolonged disruption of this capability may exacerbate or perpetuate 
the LPS-induced chronic neuroinflammatory condition. Although others 
have reported mixed results regarding the neuroprotective (Cardona, 
Pioro et al. ; Bhaskar, Konerth et al. ; Pabon, Bachstetter et al.) or 
neurodegenerative (Fuhrmann, Bittner et al. 2010; Liu, Lu et al. 2010; 
Shan, Hong-Min et al.) functions of CX3CL1-CX3CR1 signaling, such 
discrepancies may be difficult to resolve, as the role for this signaling 
pair may be dependent upon the neuropathological model examined 
and aspects of microglial function such as phagocytic activity versus 
production of pro-inflammatory cytokines.   
Our results suggest that during chronic inflammatory conditions 
when hippocampal functions are compromised and microglial cells 
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activated the altered neuron to microglia crosstalk could be 
responsible for the cognitive functions observed. These results further 
extend our understanding of the mechanisms by which chronic 
neuroinflammation might contribute to the progression of cognitive 
dysfunctions. 
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Figure 8.  Behavioral paradigm for NPR and NOR.  
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Figure 9. During the familiarization phase of the NP recognition 
test, both LPS and aCSF-infused animals explored similarly (A). 
Animals infused with artificial cerebrospinal fluid showed novel 
place recognition (70% exploration time; *p<0.05, vs. familiar 
place), whereas animals infused with LPS did not (50.9% 
exploration time) (B,C). Both aCSF and LPS-infused rats were 
able to discriminate between two object and showed novel 
object preference vs. familiar object (90 % exploration time, 
***p<0.001 vs. familiar object) (D). Taken together these data 
indicate that chronic LPS-infusion results in an hippocampal-
dependent cognitive impairment (NPR) but does not affect 
hippocampal-independent cognitive functions (NOR). 
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Figure 10. Chronic LPS-infusion disrupts FKN-CX3CR1 signaling 
the hippocampus but not the prefrontal cortex. (A) In the 
hippocamous we observed a significant decrease (p=.006) in 
the protein levels of CX3CR1, but not in the prefrontal cortex 
(B). Interestingly, when we examined the same tissue lysate for 
these regions, total CX3CL1 (soluble and membrane) was not 
altered by LPS infusion (C, D).  
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Figure 11. Chronic infusion with LPS for 28 resulted in 
significant up regulation of classical activation markers for 
microglia. (A) In the hippocampus we observed a significant 
induction (p=.004) of the proinflammatory cytokine TNF-〈 but 
not in the prefrontal cortex (B). Similarly, Notch1 was 
significantly upregulated (p=.0008) as a result of chronic LPS 
infusion in the hippocampus but not the prefrontal cortex (D).  
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Figure 12.  Chronic LPS upregulates downstream effectors 
associated with inflammation. (A) Following 28 days of 
exposure to low dose LPS, the hippocampus, but not the 
prefrontal cortex (B) had significant upregulation (p=.01) of the 
co-receptor for LPS; TLR4. Similarly, there was a significant 
change (p=.005) in the activated form of the nuclear 
transcription factor NFkB p65 in the hippocampus (C) but not 
the prefrontal cortex (D).  
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Abstract 
 The exact roles for the two types of endogenous CX3CL1 in 
neurodegenerative pathophysiology remain elusive. Recent literature 
suggests an anti-inflammatory and thus neuroprotective role for 
supraphysiological levels of exogenous CX3CL1 peptide. However, it 
has been difficult to delineate the function of the soluble and 
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membrane-bound forms of CX3CL1, as both are natively present in the 
brain. As such we sought to examine each form’s ability to regulate 
neuroinflammation in a mouse model of Parkinson’s disease initiated 
by the neurotoxin 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine!
(MPTP). We were able to delineate the function of both CX3CL1 forms 
by using AAV mediated gene therapy to selectively express synthetic 
variants of CX3CL1 that remain permanently soluble or membrane 
bound. In the present study we injected each CX3CL1 variant and a 
GFP expressing vector directly into the substantia nigra of CX3CL1-/- 
mice. Our results show for the first time that only the soluble form of 
CX3CL1 is sufficient for neuroprotection in light of exposure to MPTP. 
Specifically, we show that the soluble CX3CL1 form reduces 
impairment of motor coordination, prevents exacerbation of DA neuron 
loss, ameliorates microglia activation and proinflammatory cytokine 
release, resulting from MPTP exposure. Furthermore, the membrane-
bound form exacerbates MPTP induced pathologies.    
Introduction 
Parkinson’s disease (PD) is the third most prevalent 
neurodegenerative disorder among the aging population (Smeyne and 
Jackson-Lewis ; Przedborski). PD occurs sporadically with unknown 
etiology but presents key characteristics affecting the motor system, 
most notably resting tremor and akinesia (Bezard and Przedborski). A 
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key hallmark of PD is the dramatic depletion of dopamine (DA) 
through degeneration of DA neurons in the nigrostriatal neural 
network. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has 
been reliably used to induce DA cell loss in the nigrostriatal pathway of 
mice and non-human primates akin to what is observed in human 
condition (Przedborski, Jackson-Lewis et al.). Administration of MPTP 
in mice provokes neurodegeneration through both oxidative and 
cytotoxic methods, specifically through disruption of mitochondrial 
function and induction of microglial inflammatory mediators, 
respectively. An increasing amount of evidence has emerged to 
suggest that microglial activation is a key component contributing to 
nigrostriatal pathway degeneration and accelerating the progression of 
pathology in PD (Wu, Jackson-Lewis et al. ; Tieu, Ischiropoulos et al. ; 
Cardona, Pioro et al. ; Kim and Joh ; Yasuda, Shimoda et al.). 
Specifically, chronic activation of microglia results in the over 
production of pro-inflammatory cytokines and chemokines, as well as 
oxidative molecules leading to a neurotoxic microenvironment 
(Mantovani, Sica et al. 2004; Mosser and Edwards 2008; Cameron and 
Landreth 2010).  
As aberrant microglia activation has been routinely shown to 
contribute to the pathogenesis of PD, it is relevant to examine 
endogenous mechanisms that control neuronal-glia interactions, as 
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this is one way that neurons can signal inflammatory cells when a 
response is needed.  Under resting conditions there are several 
neuronal mediated signals that have an anti-inflammatory action at 
microglia.  One of high interest in the literature is fractalkine 
(CX3CL1). CX3CL1 is a chemokine expressed constitutively by healthy 
neurons and it has been identified as a novel neuroimmune regulatory 
protein, whose function is to send alert signals to microglia, and inhibit 
microglia activity under inflammatory conditions (Harrison, Jiang et al. 
1998; Ransohoff, Liu et al. 2007).  Several studies have suggested a 
continuous dialog between neurons and microglia under basal 
conditions via CX3CL1 and its receptor (CX3CR1) (Harrison, Jiang et 
al. 1998). Interaction between CX3CL1 and CX3CR1 contributes to 
maintain microglia in a resting phase.  Disruption of this dialog could 
trigger changes in the functional phenotype of microglia.  Accordingly, 
recent reports have begun to characterize CX3CL1-CX3CR1 
interactions as an important mechanism of microglial regulation 
(Harrison, Jiang et al. 1998; Mizutani, Sakurai et al. 2007; 
Bachstetter, Morganti et al. 2009; Wynne, Henry et al. 2010; Pabon, 
Bachstetter et al. 2011). Constitutive neuronal expression of CX3CL1 
produces a transmembrane anchored signaling subtype that can be 
targeted for proteolytic cleavage by either ADAM10/17 resulting in a 
soluble subtype, both of which have been shown to possess signaling 
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capabilities by ligating to CX3CR1 (Chapman, Moores et al. 2000; 
Garton, Gough et al. 2001; Ré and Przedborski 2006; Hundhausen, 
Schulte et al. 2007; Ludwig and Weber 2007). Functionally, the soluble 
subtype of CX3CL1 ligation to its receptor has been shown to inhibit 
microglial activation by down regulating the production of cytotoxic 
mediators (TNFα, IL-1β, iNOS, and IL-6) through p38, NFkB, and PI3K 
transduction pathways (Harrison, Jiang et al. 1998; Maciejewski-
Lenoir, Chen et al. 1999; Garcia, Xia et al. 2000; Ré and Przedborski 
2006; Ransohoff, Liu et al. 2007). Recently there has been much work 
to understand the role that neuron-glia signaling may have in various 
neurodegenerative models, specifically with the CX3CL1-CX3CR1 
signaling axis(Duan, Yang et al. 2008; Bhaskar, Konerth et al. 2010; 
Fuhrmann, Bittner et al. 2010; Lee, Varvel et al. 2010; Liu, Lu et al. 
2010; Cho, Sun et al. 2011; Pabon, Bachstetter et al. 2011; Shan, 
Hong-Min et al. 2011). Consequently, the current literature has yet to 
define a clear role for this signaling system in neurodegenerative 
animal models. Furthermore, the physiological roles of each subtype of 
CX3CL1 are not completely established in the periphery or in the CNS 
and there is considerable controversy as to the benefit or harm of 
CX3CL1 ligation to CX3CR1.  It has been shown that the membrane 
bound subtype plays a role in endothelial cell death(Yoneda, Imai et al. 
2003) whereas soluble CX3CL1 has been shown to be both 
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neuroprotective(Pabon, Bachstetter et al. 2011) and 
neurodegenerative(Shan, Hong-Min et al. 2011) in PD. To this end we 
sought to examine the signaling role of the membrane bound and 
soluble subtypes of CX3CL1 in an MPTP mouse model of PD.  
In the present study we investigated the effects of each CX3CL1 
subtype, independently (membrane bound versus soluble) expressed 
in the substantia nigra of CX3CL1 null mice exposed to MPTP. We have 
constructed two recombinant adeno-associated viruses (rAAVs) that 
selectively express soluble CX3CL1 or a mutant form, which is 
proteolytically resistant to cleavage and remains permanently 
membrane bound. rAAV9 vectors were chosen as the delivery serotype 
due to its specificity and high expression efficiency in neuronal cells.  
We observed significant reduction in neurotoxicity in MPTP exposed 
animals expressing the soluble CX3CL1 compared to those expressing 
the membrane version or control vector. 
 
Methods 
 AAV production. rAAV9 expressing the two different forms of 
fractalkine (GI:114431260) were cloned using PCR from mouse brain 
cDNA. The soluble form (sFKN; αα 1-336) was generated with primers 
Frac5’ (GAGACCGGTCCACCATGGCTCCCTCGCCGCTCGCG) and Frac3’ 
(CTCGCTAGCTCACATGGCATAGTCAGGCACGTCATAAGGATAGCTAGAAG
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CCATTGTGGCTGCCTGGGTGTCGGGGAC). The mutant membrane 
bound form (mCX3CL1; mutations to stop ADAM10/17 cleavage into 
the soluble form, R337A+R338A) was generated by cloning two PCR 
fragments with primers Frac5’ + Fracma 
(GTAGCCCCACTGCCTGGGCAGCTGTGGCTGCCTGGGTG) and Frac3’ 
(CTCGCTAGCTCACATGGCATAGTCAGGCACGTCATAAGGATAGCTAGAAG
CCATCACTGGCACCAGGACGTATGAGTTAC) and Fracms 
(CACCCAGGCAGCCACAGCTGCCCAGGCAGTGGGGCTAC). sFKN and 
mFKN were cloned into the pTR2-MCS at the Age I and Nhe I cloning 
sites. This vector contains the AAV2 terminal repeats and the hybrid 
CMV-chicken β-actin promoter for CX3CL1 mRNA transcription. An HA-
tag was added to the C-terminus of both sFKN and mFKN with the PCR 
primers. Recombinant AAV serotype 9 (rAAV9) vectors were generated 
and purified as previously described (Carty, Lee et al.). rAAV particles 
are expressed as vector genomes (v/g)/ml. Vector genomes were 
quantitated using a modified version of the dot plot protocol described 
by(Zolotukhin, Potter et al. 2002). The protocol was modified to use a 
non-radioactive biotinylated probe for fractalkine generated by PCR. 
Bound biotinylated probe was detected with IRDye 800CW (Li-Cor 
Biosciences, Lincoln, NE) and quantitated on the Li-Cor Odyssey. UF11 
plasmid was used to generate rAAV9 as described previously (Carty, 
Nash et al.). 
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 In vitro cell culture experiments. sFKN conditioned media was 
generated by transfection of HEK293 with lipofectamine 2000 
(Invitrogen) and the pTR-sFKN plasmid. Cells were incubated in Opti-
Mem (Invitrogen; containing 100U/mL penicillin and 100ug/mL 
streptomycin) for 48hrs. Following incubation, medium was harvested 
and cleared by centrifugation at 2000 x g. The cleared sFKN 
conditioned medium was used for the proceeding cell culture 
experiment.  BV2 cells were seeded at 5x105 cells per well in a 24 well 
plate in Opti-Mem (Invitrogen; supplemented containing 100U/mL 
penicillin and 100ug/mL streptomycin) and allowed to adhere for 16hr. 
Immediately prior to treatment, cells were washed with fresh medium 
to remove any dead or non-adhered cells. Cells were treated with 
conditioned media; conditioned media + LPS; LPS; or media alone for 
4 hrs. Following incubation, media was removed from each of the four 
groups and analyzed for TNFα using a commercial ELISA kit (RnD 
Systems; Minneapolis, MN) following manufacturer’s protocol.  
Animals: All experiments were conducted in accordance with the 
National Institute of Health Guide and Use of Laboratory Animals, and 
were approved by the Institutional Animal Care and Use Committee of 
the University of South Florida, College of Medicine or the University of 
Florida, as appropriate.  CX3CL1-/- mice (Merck) were backcrossed to 
the C57BL/6J (WT) background (Jackson Laboratories; Barharbor, 
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Maine) for greater than 10 generations. Colonies of C57BL/6 and 
CX3CL1-/- littermates were maintained at the University of South 
Florida and genotyping was outsourced using a commercially available 
service (Transnetyx; Cordova, TN). 12 to 16 week old C57BL/6 and 
CX3CL1-/- littermates were used in the experiments.  Mice were pair-
housed in environmentally controlled conditions (12:12 h light:dark 
cycle at 21 ± 1°C) and provided food and water ad libitum. 
 Surgical procedure. Mice for the treatment groups were 
randomly selected and age stratified to ensure equal representation. 
Three groups of 12-16 week old male CX3CL1-/- mice (n=30 per group) 
were injected with membrane-bound (mFKN), soluble (sFKN), or rAAV-
GFP (GFP) for a viral and protein control, while C57BL/6 mice were 
injected with sterile saline (C57, n=60). Mice from each rAAV group 
received 1.5 µL at 1x1012 vg/mL (2.5µL/min) bilateral direct injections 
into the SNpc (AP -2.8, ML ±1.4, DV -4.6) using a CED 26-gauge 
needle (Carty, Lee et al.). The group of C57 mice received the same 
injection parameters as the rAAV groups, instead substituting sterile 
saline. 
 Acute MPTP administration. Six weeks following injection, 
sFKN, mFKN, GFP, and C57 mice weighing between 32-41g were 
serially injected with MPTP or sterile saline as an injection control for 
naive C57 (nC57), as previously described (Cardona, Pioro et al. 
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2006). Briefly, MPTP (Sigma Aldrich; 10mg per kg body weight) was 
diluted in sterile saline and injected i.p. four times within a four hour 
period. Following injections, animal cages were placed on flexible 
water heating pads (37°C) for approximately 24 hours post injection in 
an effort to maintain body temperature and combat mortality. After 5 
days the mice were weighed, any mice that lost greater than 5% body 
mass were excluded from the study. 
 Behavioral analysis. Five days after MPTP injections, mice 
were tested for overall balance, motor coordination and motor 
learning.  This test was performed on an accelerating rotarod 
apparatus (Ugo Basile, Italy) with a 3 cm diameter rod starting at an 
initial rotation of 4 RPM accelerating to 40 RPM over 5 minutes. Mice 
were tested for the time spent on the rod during each of four trials 
with a 30 min inter-trial interval. Each trial was completed when the 
mouse fell off the rod (distance of 12 cm) onto a spring-cushioned 
lever (Rogers, Morganti et al. 2011). Following behavioral analysis, 
animals were randomly divided for either perfusions or biochemical 
analyses.   
 Immunohistochemistry. Mice were euthanized with 
pentobarbital (50 mg/kg, i.p.). The mice were transcardially perfused 
with phosphate-buffered saline (PBS), followed by 4% 
paraformaldehyde in PBS. The brains were postfixed in 4% 
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paraformaldehyde for 12 h, after which they were transferred into 
30% sucrose in PBS for at least 16 h at 4°C. Exhaustive coronal 
sections were made at 40µm using a Microm cryostat (Richard-Allan 
Scientific, Kalamazoo Michigan) and stored in cryoprotectant at 4°C. 
Labeling of dopaminergic neurons was performed using an antibody 
against tyrosine hydroxlase (TH, 1:4000, Immunostar, WI). Neurons 
were labeled using NeuN (Millipore, 1:500), which is a pan marker for 
neuronal nuclei.   Activated microglia were visualized with antibodies 
against CD68 and CD11b (Serotec 1:200). Standard staining 
procedures were conducted on free-floating sections using every sixth 
section for the entire SNpc beginning with a random start and 
including sections before and after to ensure that the entire structure 
was sampled. Following incubations (24-48hrs) with appropriate 
primary and biotinylated-secondary antibodies, sections were treated 
with vectastain ABC reagent (Vector labs) and visualized with DAB 
reaction (Sigma). As a control measure, the specificity of all antibodies 
was confirmed by omitting primary antibodies.  
Stereological quantification and imaging: To determine cell 
numbers, the optical fractionator method of unbiased stereological cell 
counting  techniques(West, Slomianka et al. 1991) was used with a 
Nikon Eclipse 600 microscope and quantified using Stereo Investigator 
software (MicroBrightField, Colchester, VT). The virtual grid (150 x 
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150) and counting frame (75 x 75) were optimized to count at least 
200 cells per animal with error coefficients less than 0.07. Outlines of 
the anatomical structures were done using 10x/0.45 objective and cell 
quantification was conducted using 60x/1.40 objective.  
 
Cell density quantification and imaging: Cell density was 
measured using a Zeiss Mirax slide scanner, as previously 
described(Rogers, Morganti et al. 2011). Briefly, slides with NeuN, 
CD68, and CD11b sections were scanned and converted into digital 
files. Following scanning, the digital images were analyzed for positive 
area using Zeiss Neuroquant IAE analysis software. An investigator 
blind to the study defined the anatomical regions comprising the SNpc 
for each tissue section. Positive cells were defined using the analysis 
software based upon their threshold to include both the cell body and 
processes, while eliminating background values. Data are represented 
as the average area ratio of positive cells relative to the total 
measurement area.  
 
Biochemical analyses tissue preparation: Mice used for 
biochemical studies were euthanatized by rapid decapitation. Brain 
tissues encompassing the ventral mesencephalon (VM) and striatum 
were separately dissected and rapidly frozen in liquid nitrogen before 
storage at -80ºC.  Tissues were homogenized using an electric tissue 
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homogenizer in 1:10 weight to volume ratio of ice-cold RIPA buffer 
(Millipore; Billerica MA) containing protease inhibitors and EDTA 
(Pierce; Rockford IL). Following homogenization, sample lysates were 
centrifuged at 10,000 x g at 4ºC for 15 minutes, the cleared 
supernatant was collected. Protein concentration was determined using 
the BCA assay (Pierce) method. Tissue lysates were used for 
subsequent Western blot and ELISA analyses. 
Western blot analysis. 50 µg of total protein per lane was 
loaded onto a 4-15% SDS-polyacrylamide gel (BioRad; Hercules, CA) 
for electrophoresis. Proteins were transferred onto a nitrocellulose 
membrane for immunodetection. Membranes were subsequently 
blocked for 1-hour in 5% non-fat dry milk (NFDM) in PBS-tween (PBS-
T, 0.1% Tween20). CX3CL1 (RnD Systems, 1:750), TH (Millipore, 
1:500), anti-HA (Roche, 1:500) and mouse beta-actin (Sigma; 
1:3000) were incubated overnight at 4oC in 1% NFDM in PBS-T. 
Following washes, anti-rabbit, anti-mouse, or anti-rat secondary 
antibodies (Li-Cor; Lincoln NE) were incubated for 1-hour at room 
temperature in 1% NFDM in PBS-T. Membranes were scanned using Li-
Cor Odyssey near infrared imager and raw intensity for each band was 
measured using Li-Cor Odyssey image analysis software. 
ELISA cytokine quantification. TNFα and IL-1β concentrations 
were quantified using standard ELISA technique. VM lysates were run 
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in triplicate at a concentration of 100 µg per well and were incubated 
over night at 4 degrees Celsius. Following incubation, manufacturer’s 
suggested protocol was followed (Raybiotech; Norcross, GA). 
Concentrations for each ELISA plate was subsequently measured on a 
plate reader (BioTek) and adjusted to the supplied standard curve. 
Values were converted from pg/mL to pg/µg of protein loaded. 
 Statisticsl analysis. All data were analyzed using SPSS (IBM, 
v20). All data are presented as the mean± standard error of the mean 
(SEM). Statistical analyses were performed using 3-way ANOVA 
accounting for genotype, MPTP, and rAAV treatments. Group 
differences were assessed by Tukey HSD post hoc multiple 
comparisons test with p values of <0.05 considered significant.  
 
Results 
 Generation of rAAV9-FKN variants and validation. Both 
rAAV9-FKN variants produce a murine version of the CX3CL1 gene 
driven by the hybrid chicken β-actin cytomegalovirus promoter and 
were tagged with hemagglutinin (HA) peptide sequence for ease of 
detection. Prior to virus production, the rAAV vector was tested in HEK 
293 cells to evaluate the expression cassette. Cell lysate and 
conditioned media from transfected cells were examined using 
Western blot analysis to determine sFKN and mFKN expression. An 
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anti-HA tag Western blot of transfected HEK 293 cells revealed that 
sFKN is readily secreted into the media, while mFKN remains only in 
the cell lysate fraction (Fig. 13a). We next wanted to ensure that the 
synthetic FKN variants were biologically active. Briefly, conditioned 
media from HEK 293 cells transfected with sFKN plasmid was used to 
confer bioactivity by measuring the amount of secreted TNFα from BV2 
microglia-like cells. It has been well documented that the induction of 
cytokine production from microglia as a result of LPS exposure can be 
blunted if the cells are pretreated with exogenous soluble CX3CL1 
peptide(Zujovic, Benavides et al. 2000; Mizuno, Kawanokuchi et al. ; 
Lyons, Lynch et al. 2009; Wynne, Henry et al. 2010). In accordance 
with previous literature, we show that BV2 cells preconditioned with 
sFKN conditioned media had an attenuated response to LPS 
(100ng/mL) as measured by TNFα secretion (Fig. 13b). Furthermore, 
addition of sFKN conditioned media alone did not induce TNFα 
production. This attenuated response is comparable to previous 
literature(Mizuno, Kawanokuchi et al. ; Lyons, Lynch et al.) given the 
dilute concentration of CX3CL1 found in sFKN conditioned media. As 
we were able to confer functionality and bioactivity in vitro we next 
examined the expression of the rAAV9-FKN vectors in vivo. Using 
CX3CL1 null mice, we injected each vector bilaterally into the SNpc. 
Six weeks post injection; harvested brain tissues were analyzed for 
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sFKN and mFKN expression by Western blot. Using an anti-mouse 
CX3CL1 antibody, in vivo expressions of each of the rAAV-FKN 
constructs created their specific variants of CX3CL1 consistent with 
predicted molecular weights as we have previously 
documented(Bachstetter, Morganti et al.)(Fig. 13c). Importantly, 
mFKN produces only a single band indicating that the mutation 
effectively prevents cleavage by ADAM10/17. Furthermore, direct 
injection using CED method(Carty, Lee et al.) with rAAV variants 
efficiently covers the entire SNpc (Fig. 13d).     
 MPTP induced impairment of motor coordination is 
ameliorated by sFKN but not mFKN. We next assessed the effects 
of each rAAV-FKN treatment on MPTP-induced motor deficits using an 
accelerating rotarod. Naive CX3CL1 null mice displayed no motor 
coordination impairment relative to nC57 (data not shown). Five days 
after the last MPTP injection, all groups displayed a trend for 
performance impairment (p<.001) as measured by average latency to 
fall through first three trials compared to nC57 (Fig. 14). Treatment 
with sFKN significantly improved MPTP-induced behavioral deficits 
compared to mFKN (p=.002) and GFP (p<.001) viral control. Following 
rotarod performance assessment, mice were killed and striatal tissues 
were dissected for biochemical analysis. In agreement with each 
group’s rotarod performance, WB analysis revealed significant loss of 
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striatal TH as a result of MPTP administration (p<.001), ranging from 
40-75% (Fig. 15a). Furthermore, sFKN treatment was able to 
attenuate exhaustive striatal TH loss by 35 and 30 percent compared 
to mFKN (p<.001) or GFP groups (p<.001), respectively.    
 
MPTP induced neurodegeneration of SNpc is rescued by 
sFKN. It has been previously documented that disruption of CX3CL1 
signaling via genetic ablation of CX3CR1 exacerbates MPTP 
neurotoxicity in SNpc of mice(Cardona, Pioro et al.). Seven days after 
the last MPTP injection mice were transcardially perfused with a 
buffered paraformaldehyde solution and brain tissues removed. We 
evaluated the level of MPTP induced neurodegeneration in the SNpc 
through stereological quantification of TH and density of NeuN 
staining. Both TH immunoreactive (Fig. 16) and NeuN (Fig. 17) labeled 
neurons mimicked our striatal TH Western blot data. Additionally, age-
matched naive CX3CL1-/- mice showed no significant reduction in the 
number of TH positive or density of NeuN stained neurons relative to 
nC57, indicating that genetic disruption of CX3CL1 signaling alone 
does not produce a phenotype (data not shown). Compared to nC57, 
MPTP produced a marked reduction in the estimated number of TH 
positive cells across all groups (p=.05). sFKN treatment attenuated 
MPTP induced dopaminergic cell loss compared to mFKN (p=.003) and 
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GFP (p<.001) treated animals. Likewise, sFKN but not mFKN 
maintained the density of NeuN labeled neurons in the SNpc 
Administration of MPTP does not alter CX3CL1-CX3CR1 
signaling. With the present study we are the first to examine MPTP 
effects on CX3CL1 signaling. Recent literature has suggested that 
acute inflammatory insults can down-regulate both transcript and 
protein levels of CX3CR1 on microglia (Kremlev and Palmer ; Wynne, 
Henry et al.). We analyzed VM tissue lysate using Western blot 
analysis for CX3CR1 (Fig. 18a). Here we are the first to report that 
acute exposure to MPTP does not affect (p=.26) the protein levels of 
CX3CR1 in vivo. Additionally, neither the presence of the individual 
rAAV-FKN variants nor the complete absence of CX3CL1 in the GFP 
group alters CX3CR1 protein levels in the VM. These data would then 
suggest that expression of CX3CR1 is not only constitutive (Harrison, 
Jiang et al.) but independent of CX3CL1 type and concentration in the 
surrounding milieu. Additionally, we quantified the production of 
CX3CL1 from each rAAV-FKN in the VM. Each rAAV-FKN was able to 
virtually restore CX3CL1 levels to that of nC57 and importantly sFKN 
and mFKN produced similar concentration of CX3CL1 (Fig. 18b). 
Furthermore, here we show for the first time that MPTP does not affect 
the production of CX3CL1 (nC57 vs. C57; p>.05).  
Induction of CD68 and CD11b reactive microglia is 
!!
99!
attenuated by sFKN.  Microglial activation has been implicated in the 
propagation of SNpc neurotoxicity in multiple animal models of PD. 
Recent studies further report that an intact CX3CL1 to CX3CR1 
signaling axis to dampen the neurotoxic effects of both 6-OHDA and 
MPTP(Cardona, Pioro et al. ; Pabon, Bachstetter et al.). Post-mortem 
analysis of idiopathic PD patients has revealed strong 
immunoreactivity for CD68, a marker of phagocytic microglia (Croisier, 
Moran et al. ; Vroon, Drukarch et al.). Furthermore, administration of 
MPTP has been reliably shown to induce this phagocytic microglia 
phenotype in the SNpc of mice (Vroon, Drukarch et al. ; Chung, Kim et 
al. ; Chung, Kim et al.). Quantification of CD68 positive cells revealed 
a significant induction of microglia reactivity (Fig. 19a) as a result of 
MPTP injections compared to saline (p=.02). CD68 immunoreactivity 
was most profound in both the mFKN (p=.001) and GFP (p<.001) 
treated groups compared to sFKN. Furthermore, sFKN treated mice 
resembled that of nC57 (p>.05) in that there were very few CD68 
positive microglia (Figs. 19b, d). Here our data also show that mice 
treated with mFKN (Fig. 19e) have a CD68 phenotype similar to mice 
expressing GFP (Fig. 19f, p>.05).   
We next analyzed broader marker for microglia activation using 
an antibody for CD11b. Immunolabeled CD11b microglia have 
previously been shown to increase reactivity following administration 
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of the dopaminergic neurotoxin MPTP in the SNpc(Wu, Teismann et al. 
; Chung, Kim et al.). Mice exposed to MPTP had a significant increase 
in CD11b reactive microglia (Fig. 20a) compared to those that received 
saline injections (p<.001). Mice that received sFKN injections again 
presented a similar CD11b expression phenotype as nC57 (p>.05). 
Further, a strong induction of CD11b density was observe in the SNpc 
of both mFKN (Fig. 20e, p<.001)  and GFP (Fig. 20f, p=.002)  treated 
mice compared to sFKN. Additionally, CD11b immunoreactivity was 
similar between mFKN and GFP treated mice (p>.05).  
 Expression of MPTP induced pro-inflammatory cytokines is 
diminished by sFKN. Post-mortem analysis of PD tissue has shown 
that microglia that are immunoreactive for multiple pro-inflammatory 
cytokines including TNFα and IL-1β(McGeer and McGeer 2004). 
Further, mice that are genetically altered to inhibit cytokine production 
or are deficient in receptors for these cytokines provide 
neuroprotection in the SNpc following MPTP exposure (Klevenyi, 
Andreassen et al. ; Sriram, Matheson et al.). Accordingly, as CX3CL1 
signaling has been shown to attenuate the production of these 
cytokines in vitro and in vivo following various inflammatory stimuli, 
we sought to examine the anti-inflammatory properties of each rAAV-
FKN variant in response to MPTP exposure. Tissue lysate of the VM 
(brain region containing SNpc) were analyzed using standard ELISA 
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techniques for the pro-inflammatory cytokines TNFα and IL-1β. MPTP 
treatment significantly upregulated the production of TNFα (Fig. 21a, 
p<.0001) and IL-1β (Fig. 21b, p<.0001) compared to all treatment 
groups. These findings are consistent with our data showing an 
increase in activated microglia (CD11b+ and CD68+) following 
exposure to MPTP. Interestingly, sFKN attenuated the production of 
both TNFα (p<.001)  and IL-1β (p<.001) compared to mFKN and GFP 
treated mice. Comparably, the production of both cytokines mimicked 
levels found in MPTP injected C57.  
Discussion 
Disruption of CX3CL1-CX3CR1 signaling in the brain exacerbates 
MPTP induced DA neurodegeneration(Cardona, Pioro et al.). 
Functionally, this signaling pair has been shown across a variety of 
studies to dampen microglial activation and subsequent toxicity. Until 
now, it has been difficult to isolate the individual effects of the two 
forms of CX3CL1. We have developed a novel method to examine the 
individual properties of each CX3CL1 form through the use of rAAV 
gene therapy in CX3CL1 null mice. Our study demonstrates that only 
sFKN is sufficient in attenuating the neurotoxic effects of MPTP on the 
nigrastriatal network. We show that treatment with sFKN reduces 
impairment of motor coordination, prevents exacerbation of DA neuron 
loss, ameliorates microglia activation and proinflammatory cytokine 
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release, all of which are commonly associated with the MPTP mouse 
model of PD.    
These important discoveries provide novel insight into the role 
for CX3CL1 signaling in an acute inflammatory state. We have 
previously reported that an exogenous truncated (i.e. soluble) peptide 
of CX3CL1 was able to reduce 6-OHDA associated neurotoxicity in a rat 
model of PD(Pabon, Bachstetter et al.). However, this model still left 
unaccounted the actions of the full-length membrane-bound CX3CL1 
subtype, as native CX3CL1 (both soluble and membrane bound) was 
still present in these animals. Additionally, Lyons et al.(2009)(Lyons, 
Lynch et al.) concluded that membrane-bound CX3CL1 possesses the 
same anti-inflammatory abilities as its soluble counterpart. However, 
Lyons et al. (2009)(Lyons, Lynch et al.) neglected to inhibit the 
constitutive cleavage mechanism of ADAM10/17 in their experimental 
paradigm. Here we have addressed this concern by mutating the 
known cleavage site of CX3CL1, thus preventing the soluble variant 
from being produced. Furthermore, by using CX3CL1 null mice, we 
were able to isolate the effects of each rAAV-FKN variant in response 
to MPTP.  
In the present study we have developed two novel rAAV vectors 
that each produce a single form of CX3CL1, either a solely soluble or 
permanently membrane-bound form. We show that in vitro the peptide 
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created by the sequence encoding sFKN attenuates the LPS-induced 
secretion of TNFα from BV2 cells. Furthermore, Western blot analysis 
of both in vitro and in vivo expression of each rAAV-FKN variant results 
in a solely soluble (sFKN) or mutated form that remains permanently 
attached to the neuronal membrane (mFKN). Additionally, the method 
of CED vector delivery (Carty, Lee et al.) efficiently saturated the SNpc 
target area with the bilateral vector bolus as confirmed by GFP 
expression in CX3CL1 null mice.  
Following the MPTP and saline injections, all mice were subjected 
to behavioral analysis to examine motor coordination. As one of the 
primary pathological hallmarks of PD in humans is motor coordination 
dysfunction (Bezard and Przedborski), it was important to characterize 
the effect that each type of our rAAV-FKN variants had on preventing 
motor coordination impairment. Five days after injection, mice 
exposed to MPTP displayed significant deficits in latency on rotarod 
apparatus compared to saline injected mice. This MPTP induced latency 
deficit was significantly ameliorated by treatment with sFKN, 
resembling that of nC57. Additionally, the full-length CX3CL1 variant 
produced by mFKN provided no amelioration of MPTP induced 
reduction of latency, as mice more closely resembled the phenotype of 
GFP injected animals.  
A pathological hallmark of PD is neurodegeneration in the SNpc 
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leading to a selective loss of DA neurons. The subsequent depletion of 
DA projections to the striatum leads to impairments in motor 
coordination. As we had observed a significant impairment in latency 
on rotarod as a result of MPTP exposure, we next examined the 
neuroprotective effects of each of our rAAV-FKN variants. Since TH is 
the rate limiting enzyme controlling the production of DA, we used this 
as a marker to selectively visualize DA neurons in the SNpc. Previous 
literature has shown an exaggerated response to MPTP in CX3CL1 
deficient mice(Cardona, Pioro et al. 2006). Mirroring the impaired 
motor coordination, we found a significant reduction of available TH in 
the striatum of MPTP treated mice. Mice expressing sFKN had 
significantly more available TH in the striatum compared to both mFKN 
and GFP expressing mice. Furthermore, stereological analysis revealed 
a significant depletion of the number of TH positive cells in the SNpc in 
response to MPTP. This depletion was again ameliorated by treatment 
with sFKN. Mimicking what was observed with latency on rotarod, 
mFKN treated mice had significantly less TH positive neurons 
compared to sFKN and resembled those treated with GFP, the rAAV 
control vector. As expression of TH has been shown to be somewhat 
plastic in response to MPTP and therefore a decline in TH is not 
necessarily an indicative marker of degenerative DA neurons (Jackson-
Lewis, Jakowec et al. 1995). In order to accurately assess whether 
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neuronal loss was occurring, we next measured the density of NeuN in 
the SNpc. Our data show that the neuronal loss associated with MPTP 
administration is recovered by administration of sFKN, while 
exacerbated by either mFKN or mice that lack any CX3CL1 (GFP).  
CX3CL1 to CX3CR1 communication is one way that neurons are 
thought to directly interact with microglia. Several studies have 
indicated that an acute inflammatory insult such as LPS exposure is 
sufficient to disrupt this dialog via down regulation of CX3CR1 
transcript and protein levels. Here we show for the first time that 
exposure to acute administration of MPTP does not affect the signaling 
capabilities of this pair as both CX3CR1 and CX3CL1 protein levels 
remain unchanged in response to MPTP exposure. Importantly, each of 
our rAAV-FKN variants restores CX3CL1 back to levels seen in wild-
type mice.  
As the aberrant activation of microglia has been shown to 
exacerbate the pathophysiology associated with PD, we examined how 
each rAAV-FKN variant was able to attenuate this response after 
administration of MPTP. Our results indicate that sFKN was able to 
abrogate the induction of CD68 phagocytic microglia, while mFKN 
dramatically induced this activation state akin to the phenotype 
present in animals injected with GFP control vector. Likewise, CD11b 
reactive microglia were markedly reduced in mice that expressed sFKN 
!!
106!
compared to both mFKN and GFP groups. Moreover, in vitro, the 
truncated (soluble) CX3CL1 peptide has been shown to reduce the 
production of multiple pro-inflammatory molecules (Zujovic, Benavides 
et al. 2000; Zujovic, Schussler et al. ; Biber, Neumann et al. ; 
Mizutani, Sakurai et al. 2007). Our current data show that sFKN 
attenuates the production of both IL-1β and TNFα in the VM of MPTP 
injected mice. Furthermore, mice expressing only the membrane-
bound form had significantly higher levels of both pro-inflammatory 
cytokines, again presenting an inflammatory phenotype similar to GFP 
expressing mice.  
There has been a recent surge in the literature regarding the role 
for CX3CL1 signaling in both physiological and pathological conditions. 
We have recently shown that genetic disruption of CX3CL1 signaling is 
sufficient to impair cognitive function (Rogers, Morganti et al.), while 
others have demonstrated both neuroprotective (Lee, Varvel et al.) 
(Fuhrmann, Bittner et al.) and neurotoxic (Bhaskar, Konerth et al.) 
effects of CX3CL1 signaling. Here we report a novel interaction 
wherein CX3CL1 mediated anti-inflammatory control of microglia is 
solely through the soluble form, in a MPTP mouse model of PD. In this 
model, through the sole interactions of sFKN and CX3CR1 we 
demonstrate amelioration of impaired motor coordination is attributed 
through a reduction in microglia activation and subsequent pro-
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inflammatory response. These effects are completely absent in mice 
expressing only a membrane-bound form of CX3CL1.  
Given that only the soluble form of CX3CL1 provides an anti-
inflammatory and therefore neuroprotective function we suggest a new 
signaling paradigm wherein ligation with the soluble form allows for 
CX3CR1 internalization. Recent literature has indicated that multiple 
chemokine receptors actively retreat through internalization to the 
cytoplasm following ligation to affect downstream signaling pathways 
(Neel, Schutyser et al. 2005; Borroni, Mantovani et al. 2010). 
Furthermore, chemokine receptor internalization may therefore play an 
important role in chemokine signaling capabilities. Given our recent 
data that show the anti-inflammatory capacity of CX3CL1 resides 
solely on the soluble form it is plausible that CX3CR1 internalization is 
functional aspect of this signaling system. Although ligation of mFKN 
with CX3CR1 is possible through the chemokine domain, its permanent 
attachment to the membrane may prevent subsequent internalization 
to the cytoplasm of microglia, thereby alter any downstream effectors. 
Therefore, only a soluble domain of CX3CL1 can be readily ligated and 
internalized with CX3CR1. Recent literature corroborate this idea in 
that CX3CR1 actively removes soluble CX3CL1 from the surrounding 
milieu, as CX3CR1 null mice have substantially more circulating 
CX3CL1(Cardona, Sasse et al. 2008). Moreover, this justifies the need 
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for the constitutive and endogenous proteolytic cleavage by 
ADAM10/17 to yield soluble CX3CL1 in an effort to maintain a constant 
neuroprotective dialog between neurons and microglia. 
We’ve created two very effective tools to examine the signaling 
characteristics of the two native forms of CX3CL1. Although we used 
an acute inflammatory model to examine these effects, it’s worth 
noting that the relationships we detailed in this study may not apply to 
all inflammatory related neurodegenerative conditions. Further 
examination of both of the CX3CL1 subtypes in various animal models 
of neuroinflammation and degenerative disease models are necessary 
to continue our understanding of this unique chemokine signaling pair.  
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Figure 13. Generation of rAAV-FKN variants. (A) Western blot analysis of 
sFKN (s), mFKN (m), and GFP expressed in 293 cells using an anti-
hemagglutinin antibody. Only sFKN was detected in the media. (B) 
ELISA quantification of BV2 secreted TNFα. Pre-treatment with sFKN 
conditioned media attenuates (p<.05) the secretion of TNFα from BV2 
cells when exposed to 100ng of LPS for 4hrs. sFKN alone does not 
induce the secretion of TNFα. (C) Western blot analysis of in vivo 
expression of sFKN (s) and mFKN (m) using an anti-CX3CL1 antibody. 
Both sFKN (s) and mFKN (m) produce a single band consistent in 
molecular weight with previous literature. Importantly, mFKN (m) yields 
only a single band indicating that endogenous ADAM10/17 proteolytic 
cleavage is prevented. (D) In vivo transduction of rAAV-GFP in the SNpc 
neurons (inset). CED vector delivery resulted in complete coverage of 
the SNpc. Scale bar is 200µm. Data are presented as mean±SEM. 
s m
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Figure 14. MPTP induced impairment of motor coordination is 
rescued by sFKN. Five days after the last injection of MPTP, mice 
were subjected to behavioral analysis to analyze balance and 
coordination on an accelerating rotarod. Motor coordination was 
assessed using the first three of four trials during training. As a 
whole, MPTP induced significant deficits in motor coordination 
through the first three trials compared to nC57 (Repeated 
measures ANOVA; p<.001). Treatment with sFKN attenuated MPTP 
induced coordination deficits compared to mFKN (p=.002) and GFP 
(p<.001). Data are presented as mean time in seconds as a 
percentage of nC57 ± SEM.
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Figure 15. Western blot analysis of TH in Striatum. Both hemispheres of the striatum 
were rapidly dissected seven days after the last MPTP injection for biochemical 
analysis. (A) Western blot analysis revealed that MPTP significantly reduced, by 
approximately 40% the availability of TH in the striatum compared to saline control 
nC57 (p=.002). Mice that received sFKN had an attenuated loss of TH in the striatum 
compared to mFKN (p<.001) and GFP (p<.001). Furthermore, mFKN and GFP groups 
displayed approximately a 76% and 70% reduction in TH, respectively. (B-F) 
Representative immunostaining in the striatum shows progressive loss of TH for (B) 
nC57, (C) C57, (D) sFKN, (E) mFKN, and (F) GFP groups. Data are presented as the 
mean band density ratio (n=5 per group) of TH to Actin as a percentage of nC57 ± 
SEM. au= arbitrary units. Scale bar equals 200µm.
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Figure 16. Stereological analysis of TH-positive neurons in SNpc. TH 
immunoreactivity was analyzed in the SNpc of mice seven days after 
the last MPTP injection. (A)Exposure to MPTP resulted in a marked 
reduction in the number of TH-positive cells in the SNpc (p=.05) 
compared to saline treated nC57 mice. sFKN provided the greatest 
TH-neuroprotection relative to mFKN (p=.003) and GFP (p<.001). (B-
F) Representative immunostaining for  TH in SNpc for (B) nC57, (C) 
C57, (D) sFKN, (E) mFKN, and (F) GFP. Data are presented as mean 
estimate of TH positive cells (n=6 per group) as a percentage of nC57 
± SEM. Scale bar equals 200µm.
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Figure 17.  Densitometric analysis of NeuN positive neurons in the 
SNpc. NeuN immunoreactivity was quantified in the SNpc of mice 
from tissue taken seven days after last MPTP injection. (A) 
Densitometric analysis of NeuN immunostaining in the SNpc 
revealed a significant decline in immunoreactivity due to MPTP 
exposure compared to saline (p<.01). Additionally, sFKN mice had 
significantly more NeuN positive cells in the SNpc compared to 
mFKN (p<.05). There was no difference between mFKN and GFP 
groups as well as an analogous trend for mFKN and GFP compared 
to sFKN. (B-F) Representative staining for NeuN in SNpc for (B) 
nC57, (C) C57, (D) sFKN, (E) mFKN, and (F) GFP. Data are 
presented as mean ± SEM. Scale bar equals 200µm. 
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Figure 18. MPTP does not adversely affect CX3CL1-CX3CR1 signaling in VM. 
Tissue lysates from the VM of each group were analyzed for protein levels of 
CX3CR1 by Western blot and CX3CL1 by ELISA. (A) Western blot analysis of 
VM tissue lysate using an anti-CX3CR1 antibody revealed no significant 
changes as a result of either MPTP or saline injections. Furthermore, neither 
the presence nor absence of CX3CL1 affected protein levels of CX3CR1. (B) 
Standard ELISA technique was used to quantify total CX3CL1 levels. 
Exposure to MPTP did not affect the production of CX3CL1 (nC57 vs. C57). 
Furthermore, each rAAV-FKN variant expressed approximately the same 
amount of CX3CL1 and importantly restored CX3CL1 to that of levels wild 
type (nC57) mice.  Data are presented for Western blot as the mean band 
density ratio (n=5 per group) of CX3CR1 to Actin ± SEM. au= arbitrary units.
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Figure 19. MPTP significantly induces expression of CD68 reactive 
microglia. (A) Densitometric analysis of CD68 immunoreactive 
microglia in the SNpc. CD68 immunoreactivity was noticeably absent 
in both nC57 and sFKN groups. Additionally, sFKN treatment 
prevented the abberrant accumulation of CD68 microglia compared to 
both mFKN (p=.001) and GFP (p<.0001). (B-F) Representative CD68 
reactive microglia immunostaining in the SNpc shows aberrant 
accumulation of activated microglia for (B) nC57, (C) C57, (D) sFKN, 
(E) mFKN, and (F) GFP groups. Data are presented as the mean band 
density ratio (n=5 per group) of TH to Actin as a percentage of nC57 
± SEM. Scale bar equals 200µm.
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Figure 20. MPTP significantly induces expression of CD11b 
reactive microglia. (A) Densitometric analysis of CD11b 
immunoreactive microglia in the SNpc. sFKN treatment 
prevented the abberrant accumulation of CD11b microglia 
compared to both mFKN (p=.0001) and GFP (p<.002). (B-F) 
Representative CD11b reactive microglia immunostaining in the 
SNpc shows aberrant accumulation of activated microglia for (B) 
nC57, (C) C57, (D) sFKN, (E) mFKN, and (F) GFP groups. Data 
are presented as the mean band density ratio (n=5 per group) 
of TH to Actin as a percentage of nC57 ± SEM. Scale bar equals 
200µm.
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Figure 21. MPTP induction of pro-inflammatory cytokines is 
ameliorated by sFKN. Tissue lysate from VM of each group (n=5 per 
group) was analyzed to quantify the production of the pro-
inflammatory cytokines TNFα and IL-1β. (A) MPTP induced 
production of TNFα is ameliorated by sFKN compared to mFKN (p<.
0001) and GFP (p=.0009). (B) Quantification of IL-1β levels 
revealed the same trend, as sFKN significantly attenuated 
production compared to mFKN (p=.001) and GFP (p=.0009). Data 
are presented as the mean ± SEM.
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Conclusions: CX3CL1-CX3CR1 signaling axis regulates cognitive 
function and combats neurodegeneration through governing of 
microglia activation. 
Introduction 
 
 Neuroinflammation is widely recognized as a contributing factor to 
the progression of many neurodegenerative diseases such as AD and 
PD. It is both axiomatic and problematic the inherent role that 
neuroinflammation plays in aging and cognitive function, as well as 
progression of neurodegenerative pathology. To this point, it has been 
suggested that the process of aging in the brain, through a lifelong 
accumulation of various insults, transforms the innate immunological 
response to a chronically inflamed state, thus predisposing itself to 
neurodegenerative disease (Blasko, Stampfer-Kountchev et al. 2004). 
It is not surprising then the correlation between the use of anti-
inflammatory drugs and the reduced risk of developing 
neurodegenerative pathology (Chen, Zhang et al. 2003). Likewise, the 
CNS has several endogenous anti-inflammatory signaling mechanisms 
to combat development of inflammation. Here, in the preceding 
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chapters we analyzed how CX3CL1 anti-inflammatory effects impact 
cognitive function and progression of neurodegeneration.  
  
Microglia: the brain’s double agent. 
 
 The brain’s resident immune cells, acting in much the same way 
as peripheral macrophages, are microglia. While histology has 
revealed that microglia densities vary regionally within the brain, it 
must be noted that both the hippocampus and substantia nigra contain 
the highest concentrations (Lawson, Perry et al. 1990; Kim, Mohney et 
al. 2000). Under non-pathological conditions in the mature brain, 
microglia are typically found in a resting state with small soma and 
highly ramified projections to monitor their surrounding environment 
(Nimmerjahn, Kirchhoff et al. 2005). Continuing controversy exists as 
to the exact nature of microglia, whether they are inherently 
neuroprotective or neurotoxic when activated. When presented with 
certain immunological cues or insults such as brain injury, microglia 
become promptly activated (Fetler and Amigorena 2005). The term 
‘activation’ when referring to microglia often carries a harmful 
connotation, which is not always the case. Microglia activation can 
have a beneficial role, they remove neural cells programmed for death 
and facilitate formation of synapses in the developing brain (Upender 
and Naegele 1999; Paolicelli, Bolasco et al. 2011), and release anti-
inflammatory and trophic factors (Morgan, Taylor et al. 2004). 
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However, as the previous chapters have highlighted, activation of 
microglia often result in a cytotoxic response, with damaging effects 
on nearby neurons. If microglia simply existed as cytotoxic 
contributors, the clear therapeutic treatment would be ablation of 
function entirely. Notwithstanding, it has been shown that indeed the 
brain does need controlled cytotoxic responses in order to curtail long 
lasting damage (Gemma, Catlow et al. 2007).   
 
Cytokines: a necessary evil.    
 It is difficult to pinpoint the exact cause or specific mechanisms 
related to the cognitive impairments associated with inflammation as 
there are likely many. Further complicating the matter is the 
involvement of cytokines in the maintenance of synaptic function. 
Although the over production of cytokines in response to various 
stimuli can negatively affect many neural functions, it then would 
seem almost counterintuitive that these very products are actual 
necessities for proper cognitive function. One of the more widely 
studied cytokines that has this dual nature of beneficial and toxic is IL-
1B (Goshen, Kreisel et al. 2007). As such, it has been shown that IL-
1B signaling follows an inverted curve; lower concentrations are 
beneficial (Brennan, Beck et al. 2003) if not necessary, while higher 
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concentrations impair synaptic plasticity (Rachal Pugh, Fleshner et al. 
2001). Corroborating this idea are data showing that knock-out of IL-1 
receptor in mice resulted in impaired memory, which coincided with 
reductions is synaptic plasticity (Avital, Goshen et al. 2003), whereas 
over-expression of IL-1B resulted in impaired LTP-associated learning 
(Deak 2007).    
 Another cytokine with pleiotropic actions is TNFa. This pro-
inflammatory cytokine has been shown to provide physiological 
(Cheng, Christakos et al. 1994), neuroprotective (Gemma, Catlow et 
al. 2007), and neurodegenerative (Perry, Collins et al. 2001) effects. 
Therefore it may be difficult to establish a unique role for this cytokine 
in the CNS, which may be in part to due its receptors. An idiosyncrasy 
of TNF are its two receptor subtypes (r1 and r2); both of which may 
have different signaling purposes. TNF-r1 is for the most part thought 
of as the inflammatory component of TNF mediated inflammation, in 
that it has been shown to activate caspases (MacEwan 2002). While 
TNF-r2 appears to have the opposite effects due to a lack the 
apoptosis signaling domain present in TNF-r1 (MacEwan 2002). The 
exact role of TNF signaling as it relates to synaptic plasticity is not well 
defined, however recent literature seem to implicate a role for 
modulation of glutamatergic signaling. Interestingly, TNF may up-
regulate the expression of AMPA receptors at the synapse, while 
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simultaneously down-regulating GABA receptors through endocytosis; 
resulting in a net increase of synaptic signaling (Stellwagen, Beattie et 
al. 2005). Coincidentally, the tight regulation of AMPA receptors at the 
synapse is important for both LTP and LTD (Malenka and Bear 2004). 
Thus it may be plausible that low levels of TNF are responsible for 
regulating synaptic plasticity.    
 Related to synaptic plasticity and its impacts on cognitive 
function, microglia and their respective pro-inflammatory mediators 
are, in essence, a necessary evil. Both the over production and 
absence of cytokines have been shown to affect hippocampal 
dependent forms of cognitive function and synaptic plasticity. As such, 
a cytokine model of cognitive function (McAfoose and Baune 2009), 
has been proposed due to the inherent nature for cytokines to regulate 
synaptic plasticity and ultimately cognitive function.    
 We have demonstrated that disruption of CX3CL1 signaling by 
genetically removing CX3CR1 leads to impairments in synaptic 
plasticity and cognitive function. Furthermore, these impairments are 
related to a chronic overproduction of both IL1B and TNFa relative to 
wild-type mice. Additionally, ventricular infusion of IL-1ra recovered 
cognitive deficits associated with CX3CR1 null mice, suggesting a 
prominent link between CX3CR1 deficiency, IL1B production, and 
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synaptic plasticity. While we did observe increased TNFa in the 
cerebellum of CX3CR1 null mice, we would also assume the same 
increase exists in the hippocampus. To that end, blockade of TNF 
production has been shown to recover cognitive deficits in AD patients 
(Tobinick and Gross 2008; Tobinick 2009), therefore administration of 
TNF blocking compounds could yield similar results as IL-1ra in our 
current study.     
 Although genetic ablation of CX3CR1 resulted in a chronic 
inflammatory phenotype, we used another approach to examine 
chronic neuroinflammation. By using low-dose infusion of LPS into the 
third ventricle we were able to trigger a strong microglia inflammatory 
response. As a result, rats infused with LPS showed significant 
impairments in novel place recognition, a preferentially hippocampal 
dependent task (Morris, Garrud et al. 1982; Mumby, Gaskin et al. 
2002; Barker and Warburton 2011) but not novel object recognition, a 
task that relies on the perirhinal cortex (Steckler, Drinkenburg et al. 
1998; Aggleton and Brown 1999; Mumby, Gaskin et al. 2002; Barker 
and Warburton 2011). This behavioral phenotype is highly consistent 
with the fact that neuroinflammation is primarily distributed within the 
hippocampus in our model (Rosi, Ramirez-Amaya et al. 2005; Rosi, 
Vazdarjanova et al. 2006) and further demonstrates the high 
vulnerability of the hippocampal formation toward neuroinflammation. 
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Interestingly, as a result of chronic LPS exposure, CX3CR1 was 
dramatically reduced in the hippocampus. Analogous to our study with 
CX3CR1 null mice, we observed a dramatic induction of TNFa as well 
as signaling components involved in the propagation of 
neuroinflammation.   
 Although we used two distinct models to study chronic 
neuroinflammation, parallels can be drawn from both. In general, the 
resultant exposure to chronic supraphysiological levels of cytokines 
resulted in impairment of cognitive function. As chronic 
neuroinflammation has previously been shown to alter glutamatergic 
signaling {Fine, 1996, r04380; Espey, 1998, r04381}, it is plausible to 
hypothesize that the increase in neuroinflammation we observed in 
both studies altered glutamate signaling and/or excitotoxicity. To this 
point, administration of a non-specific NMDAr antagonist reversed 
glutamatergic related cognitive impairments induced by chronic LPS-
infusion (Rosi, Vazdarjanova et al. 2006). Moreover, CX3CL1 has been 
shown to protect hippocampal neurons from glutamate mediated 
exicitoxicity in the rat brain (Limatola, Lauro et al. 2005). While both 
of our studies further corroborate a role for cytokines and their 
regulation of cognitive function, it is still difficult to establish an exact 
mechanism. Further characterization of the pleiotropic functions of 
various cytokines is needed to fully realize their roles in the modeling 
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of synapses and cognitive function.  
CX3CL1: a potent regulator of microglia. 
 While the ablation of microglial activity would prove detrimental 
on many levels, mechanisms (endogenous or therapeutic) are needed 
to limit the production of cytokines and other inflammatory factors. 
Constitutive expression of several ligand-receptor pairs such as 
CD200-CD200r, SIRPalpha-CD47, CD22-CD47, and CX3CL1-CX3CR1 
allow neuron-microglia communication (Hoek, Ruuls et al. 2000; 
Cardona, Pioro et al. 2006; Bessis, Béchade et al. 2007). All of these 
signaling pairs have been shown to have roles to regulate microglia 
reactivity. Importantly, these signaling pairs do not control microglia in 
a polar sense, in that presence does not entail microglial activity 
inhibition. Which contrasts sharply with known inhibitory molecules 
such as IL-10, TGFb, glucocorticoids, and minocycline. In that sense, 
constitutive neuron-microglia signaling should be thought of as a 
regulator of activation, wherein disruptions (e.g. neuronal damage) in 
these signaling pairs could be a key signal to shift into different 
activation phenotypes as previously described.   
 CX3CL1 signaling has been implicated in the regulation of 
neurotoxic microglia in a variety of pathological conditions, as 
previously reviewed. However, we were able to isolate the effects of 
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the two endogenous subtypes of CX3CL1 in an MPTP mouse model of 
PD. Subsequently, we have begun to establish that only the soluble 
subtype of CX3CL1 possesses the ability to regulate microglia toxicity 
in light of exposure to MPTP. This model presents an interesting 
paradigm to study CX3CL1 effects on microglia activation. As 
previously mentioned, the area affected (SNpc) is highly susceptible to 
damage due to an inability to cope with oxidative stress and high 
concentrations of microglia. In light of these observations, MPTP 
exposure results in a toxic insult that is multifaceted and self 
propagating. To this point, MPTP  or its metabolite MPP+ has no known 
direct link (or receptor) with microglia, activation of microglia is a 
secondary inflammatory response to degenerating neurons, which in 
turn creates a neurotoxic microenvironment surrounding the 
degenerative DA neurons. The perpetuating insult will in turn damage 
by-standard  neurons (DA and non) that are healthy, creating a vicious 
feed back loop. When dysregulation of microglia occurs through 
disruption of CX3CL1 signaling, either the absence of CX3CL1 or the 
presence of only a membrane-bound form, MPTP driven neurotoxicity 
is exacerbated. While the idea that removal of CX3CL1 signaing  
exacerbates neurotoxicity was previously well established(Cardona, 
Pioro et al. 2006), our findings detailing the inability for the 
membrane-bound form to regulate microglia toxicity are quite unique. 
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These findings are confusing in the sense that the membrane-bound 
form still possesses an identical signaling domain as its soluble 
contemporary.  This could be accounted by assuming that neurons do 
not physically contact with microglia, however this has been shown not 
to be the case (Paolicelli, Bolasco et al. 2011). Contrary to our chronic 
models, MPTP does not affect CX3CR1 availability, so there is signaling 
capability on microglia. Herein lies a difficult interpretation of our 
results. There are distinct possibilities regarding the apparent passivity 
of the membrane-bound subtype of CX3CL1.   
 First, the two subtypes of CX3CL1 are anti-inflammatory (soluble) 
or neurotoxic (membrane-bound). In this sense, the accumulation of 
activated microglia, induction of inflammation, and subsequent 
neuronal damage are due to signaling from the membrane-bound 
subtype. This could be plausible as peripheral immune cells have been 
shown to up regulate inflammatory factors in response to membrane-
bound CX3CL1 (Yoneda, Imai et al. 2003). However, in our model this 
does not seem as likely. Proteolytic cleavage of CX3CL1 from 
membrane is constitutively mediated by ADAM10/17. Notably, 
ADAM17 is also responsible for cleavage of pro-TNFa to its active form. 
As there is a subsequent induction of TNFa in MPTP treated mice, it 
must be assumed that this cleavage mechanism is still functionally 
intact. For the membrane-bound form to have a functional 
!!
128!
significance, or inflammatory signaling role there would have to be a 
coincidental alteration of ADAM17 activity and subsequent down-
regulation of TNFa production. Thus, this would imply a TNF-
independent, possibly inflammasome related pathway of membrane-
bound CX3CL1 inflammatory signaling. Here our data would suggest 
otherwise, as there was strong inductions of both pro-inflammatory 
pathways. Additionally, the proteolytic cleavage of CX3CL1 actually 
appears to be induced by toxic insult preceding neuronal damage 
(Chapman, Moores et al. 2000). The concomitant link between TNFa 
production and the solubilization of CX3CL1 would then suggest a 
modulatory role.   A case for retaining the membrane-bound form may 
difficult to resolve as it seems to remain passive in response to MPTP 
exposure. Function of various types of chemokine receptors rely on 
downstream signaling induced by receptor internalization. The 
passivity of membrane-bound CX3CL1 could be resolved by the 
hypothesis that remaining attached the membrane prevents receptor 
internalization after binding, thus preventing similar anti-inflammatory 
actions as its soluble contemporary. Multiple chemokine receptors 
internalize following ligation to affect downstream signaling pathways 
(Neel, Schutyser et al. 2005; Savarin-Vuaillat and Ransohoff 2007; 
Borroni, Mantovani et al. 2010). Functionally, this hypothesis could be 
tested by using sodium azide(Chen, Luo et al. 2002) to inhibit receptor 
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internalization comparing mFKN versus sFKN using similar outputs as 
our MPTP study.   
 Our MPTP model evaluating the various subtypes of CX3CL1 
yielded some very intriguing results that may ultimately create more 
questions than it answers. The predominant question is the ambiguity 
of membrane-bound CX3CL1 in neurotoxic environments. At least in 
our model, we show that this subtype is passive in that it doesn’t 
provide the same neuroprotective effects as its soluble contemporary. 
It may be that attachment to the membrane provides a repository 
type function, essentially banking unneeded CX3CL1 in case various 
insults or inflammatory events present themselves. Due to the toxic 
pathway of MPTP, in our model the soluble CX3CL1 subtype acts as a 
triage mechanism, preventing exacerbation of neurotoxicity.     
Conclusion 
 
An axiom of aging is a concomitant increase in 
neuroinflammation, which may predispose the brain to development of 
cognitive impairment (dementia) as well as neurodegenerative 
diseases such as AD and PD. The exact mechanisms underlying 
increased inflammation in the brain remain ambiguous. However, what 
is apparent is the need to regulate neuroinflammation, so that host 
defense responses to insult, injury and infection are viable yet 
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restrained. Inflammatory responses must be appropriately gated to 
suit such events in order to prevent aberrant accumulation pro-
inflammatory molecules/mediators. Implications of unregulated 
chronic and acute neuroinflammation were demonstrated in the 
previous three chapters’ findings. Furthermore, a novel tool for 
examining the various nuances of CX3CL1 signaling was created and 
future implications in other neurodegenerative models such as AD 
remain unknown. As such, future studies may be able to define a role 
for membrane-bound CX3CL1, where our PD model could not. 
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